46 results on '"J, Trujillano Cabello"'
Search Results
2. ESICM LIVES 2016: part one
- Author
-
L. Bos, L. Schouten, L. van Vught, M. Wiewel, D. Ong, O. Cremer, A. Artigas, I. Martin-Loeches, A. Hoogendijk, T. van der Poll, J. Horn, N. Juffermans, M. Schultz, N. de Prost, T. Pham, G. Carteaux, A. Mekontso Dessap, C. Brun-Buisson, E. Fan, G. Bellani, J. Laffey, A. Mercat, L. Brochard, B. Maitre, LUNG SAFE investigators and the ESICM study group, P. A. Howells, D. R. Thickett, C. Knox, D. P. Park, F. Gao, O. Tucker, T. Whitehouse, D. F. McAuley, G. D. Perkins, LUNG SAFE Investigators and the ESICM Trials Group, L. Pisani, J. P. Roozeman, F. D. Simonis, A. Giangregorio, L. R. Schouten, S. M. Van der Hoeven, A. Serpa Neto, E. Festic, A. M. Dondorp, S. Grasso, L. D. Bos, M. J. Schultz, M. Koster-Brouwer, D. Verboom, B. Scicluna, K. van de Groep, J. Frencken, M. Bonten, J. I. Ko, K. S. Kim, G. J. Suh, W. Y. Kwon, K. Kim, J. H. Shin, O. T. Ranzani, E. Prina, R. Menendez, A. Ceccato, R. Mendez, C. Cilloniz, A. Gabarrus, M. Ferrer, A. Torres, A. Urbano, L. A. Zhang, D. Swigon, F. Pike, R. S. Parker, G. Clermont, C. Scheer, S. O. Kuhn, A. Modler, M. Vollmer, C. Fuchs, K. Hahnenkamp, S. Rehberg, M. Gründling, A. Taggu, N. Darang, N. Öveges, I. László, K. Tánczos, M. Németh, G. Lebák, B. Tudor, D. Érces, J. Kaszaki, W. Huber, D. Trásy, Z. Molnár, G. Ferrara, V. S. Kanoore Edul, H. S. Canales, E. Martins, C. Canullán, G. Murias, M. O. Pozo, J. F. Caminos Eguillor, M. G. Buscetti, C. Ince, A. Dubin, H. D. Aya, A. Rhodes, N. Fletcher, R. M. Grounds, M. Cecconi, M. Jacquet-Lagrèze, M. Riche, R. Schweizer, P. Portran, W. Fornier, M. Lilot, J. Neidecker, J. L. Fellahi, A. Escoresca-Ortega, A. Gutiérrez-Pizarraya, L. Charris-Castro, Y. Corcia-Palomo, E. Fernandez-Delgado, J. Garnacho-Montero, C. Roger, L. Muller, L. Elotmani, J. Lipman, J. Y. Lefrant, J. A. Roberts, R. Muñoz-Bermúdez, M. Samper, C. Climent, F. Vasco, V. Sara, S. Luque, N. Campillo, S. Grau Cerrato, J. R. Masclans, F. Alvarez-Lerma, S. Carvalho Brugger, G. Jimenez Jimenez, M. Miralbés Torner, J. Trujillano Cabello, B. Balsera Garrido, X. Nuvials Casals, F. Barcenilla Gaite, M. Vallverdú Vidal, M. Palomar Martínez, V. Gusarov, D. Shilkin, M. Dementienko, E. Nesterova, N. Lashenkova, A. Kuzovlev, M. Zamyatin, A. Demoule, S. Carreira, S. Lavault, O. Palancca, E. Morawiec, J. Mayaux, I. Arnulf, T. Similowski, B. S. Rasmussen, R. G. Maltesen, M. Hanifa, S. Pedersen, S. R. Kristensen, R. Wimmer, M. Panigada, G. Li Bassi, T. Kolobow, A. Zanella, M. Cressoni, L. Berra, V. Parrini, H. Kandil, G. Salati, S. Livigni, A. Amatu, A. Andreotti, F. Tagliaferri, G. Moise, G. Mercurio, A. Costa, A. Vezzani, S. Lindau, J. Babel, M. Cavana, D. Consonni, A. Pesenti, L. Gattinoni, for the GRAVITY-VAP TRIAL NETWORK, P. Mansouri, F. Zand, L. Zahed, F. Dehghanrad, M. Bahrani, M. Ghorbani, B. Cambiaghi, O. Moerer, T. Mauri, N. Kunze-Szikszay, C. Ritter, M. Quintel, L. M. Vilander, M. A. Kaunisto, S. T. Vaara, V. Pettilä, FINNAKI Study Group, J. L. G. Haitsma Mulier, S. Rozemeijer, A. M. E. Spoelstra-de Man, P. E. Elbers, P. R. Tuinman, M. C. de Waard, H. M. Oudemans-van Straaten, A. M. A. Liberatore, R. B. Souza, A. M. C. R. P. F. Martins, J. C. F. Vieira, I. H. J. Koh, M. Galindo Martínez, R. Jiménez Sánchez, L. Martínez Gascón, M. D. Rodríguez Mulero, A. Ortín Freire, A. Ojados Muñoz, S. Rebollo Acebes, Á. Fernández Martínez, S. Moreno Aliaga, L. Herrera Para, J. Murcia Payá, F. Rodríguez Mulero, P. Guerci, Y. Ince, P. Heeman, B. Ergin, Z. Uz, M. Massey, R. Papatella, E. Bulent, F. Toraman, E. R. Longbottom, H. D. Torrance, H. C. Owen, C. J. Hinds, R. M. Pearse, M. J. O’Dywer, Z. Trogrlic, M. van der Jagt, H. Lingsma, H. H. Ponssen, J. F. Schoonderbeek, F. Schreiner, S. J. Verbrugge, S. Duran, T. van Achterberg, J. Bakker, D. A. M. P. J. Gommers, E. Ista, A. Krajčová, P. Waldauf, F. Duška, A. Shah, N. Roy, S. McKechnie, C. Doree, S. Fisher, S. J. Stanworth, J. F. Jensen, D. Overgaard, M. H. Bestle, D. F. Christensen, I. Egerod, The RAPIT Group, A. Pivkina, I. Zhivotneva, N. Pasko, A. Alklit, R. L. Hansen, H. Knudsen, L. B. Grode, The RAPIT group, M. Hravnak, L. Chen, A. Dubrawski, M. R. Pinsky, S. M. Parry, L. D. Knight, B. C. Connolly, C. E. Baldwin, Z. A. Puthucheary, L. Denehy, N. Hart, P. E. Morris, J. Mortimore, C. L. Granger, H. I. Jensen, R. Piers, B. Van den Bulcke, J. Malmgren, V. Metaxa, A. K. Reyners, M. Darmon, K. Rusinova, D. Talmor, A. P. Meert, L. Cancelliere, L. Zubek, P. Maia, A. Michalsen, J. Decruyenaere, E. Kompanje, S. Vanheule, E. Azoulay, S. Vansteelandt, D. Benoit, C. Ryan, D. Dawson, J. Ball, K. Noone, B. Aisling, S. Prudden, A. Ntantana, D. Matamis, S. Savvidou, M. Giannakou, M. Gouva, G. Nakos, V. Koulouras, J. Aron, G. Lumley, D. Milliken, K. Dhadwal, B. A. McGrath, S. J. Lynch, B. Bovento, G. Sharpe, E. Grainger, S. Pieri-Davies, S. Wallace, B. McGrath, M. Jung, J. Cho, H. Park, G. Suh, O. Kousha, J. Paddle, L. Gamrin Gripenberg, M. Sundström Rehal, J. Wernerman, O. Rooyackers, H. J. de Grooth, W. P. Choo, A. M. Spoelstra-de Man, E. L. Swart, L. Talan, G. Güven, N. D. Altıntas, M. Padar, G. Uusvel, L. Starkopf, J. Starkopf, A. Reintam Blaser, M. S. Kalaiselvan, A. S. Arunkumar, M. K. Renuka, R. L. Shivkumar, M. Volbeda, D. ten Kate, M. Hoekstra, J. M. van der Maaten, M. W. Nijsten, A. Komaromi, Å. Norberg, M. Smedberg, M. Mori, L. Pettersson, M. Theodorakopoulou, T. Christodoulopoulou, A. Diamantakis, F. Frantzeskaki, M. Kontogiorgi, E. Chrysanthopoulou, M. Lygnos, C. Diakaki, A. Armaganidis, K. Gundogan, E. Dogan, R. Coskun, S. Muhtaroglu, M. Sungur, T. Ziegler, M. Guven, A. Kleyman, W. Khaliq, D. Andreas, M. Singer, R. Meierhans, R. Schuepbach, I. De Brito-Ashurst, G. Sabetian, R. Nikandish, F. Hagar, M. Masjedi, B. Maghsudi, A. Vazin, E. Asadpour, K. C. Kao, L. C. Chiu, C. Y. Hung, C. H. Chang, S. H. Li, H. C. Hu, S. El Maraghi, M. Ali, D. Rageb, M. Helmy, J. Marin-Corral, C. Vilà, A. Vàzquez, I. Martín-Loeches, E. Díaz, J. C. Yébenes, A. Rodriguez, F. Álvarez-Lerma, H1N1 SEMICYUC/GETGAG Working Group, N. Varga, A. Cortina-Gutiérrez, L. Dono, M. Martínez-Martínez, C. Maldonado, E. Papiol, M. Pérez-Carrasco, R. Ferrer, K. Nweze, B. Morton, I. Welters, M. Houard, B. Voisin, G. Ledoux, S. Six, E. Jaillette, S. Nseir, S. Romdhani, R. Bouneb, D. Loghmari, N. Ben Aicha, J. Ayachi, K. Meddeb, I. Chouchène, A. Khedher, M. Boussarsar, K. S. Chan, W. L. Yu, J. Nolla, L. Vidaur, J. Bonastre, B. Suberbiola, J. E. Guerrero, H1N1 SEMICYUC/GETGAG working group, N. Ramon Coll, G. Jiménez Jiménez, J. Codina Calero, M. García, M. C. de la Torre, E. Vendrell, E. Palomera, E. Güell, M. Serra-Prat, J. F. Bermejo-Martín, J. Almirall, E. Tomas, A. Escoval, F. Froe, M. H. Vitoria Pereira, N. Velez, E. Viegas, E. Filipe, C. Groves, M. Reay, A. Ballin, F. Facchin, G. Sartori, F. Zarantonello, E. Campello, C. M. Radu, S. Rossi, C. Ori, P. Simioni, N. Umei, I. Shingo, A. C. Santos, C. Candeias, I. Moniz, R. Marçal, Z. Costa e Silva, J. M. Ribeiro, J. F. Georger, J. P. Ponthus, M. Tchir, V. Amilien, M. Ayoub, E. Barsam, G. Martucci, G. Panarello, F. Tuzzolino, G. Capitanio, V. Ferrazza, T. Carollo, L. Giovanni, A. Arcadipane, M. López Sánchez, M. A. González-Gay, F. J. Llorca Díaz, M. I. Rubio López, E. Zogheib, L. Villeret, J. Nader, M. Bernasinski, P. Besserve, T. Caus, H. Dupont, P. Morimont, S. Habran, R. Hubert, T. Desaive, F. Blaffart, N. Janssen, J. Guiot, A. Pironet, P. Dauby, B. Lambermont, T. Pettenuzzo, G. Citton, C. Kirakli, O. Ediboglu, S. Ataman, M. Yarici, F. Tuksavul, S. Keating, A. Gibson, M. Gilles, M. Dunn, G. Price, N. Young, P. Remeta, P. Bishop, M. D. Fernández Zamora, J. Muñoz-Bono, E. Curiel-Balsera, E. Aguilar-Alonso, R. Hinojosa, A. Gordillo-Brenes, J. A. Arboleda-Sánchez, ARIAM-CARDIAC SURGERY PROJECT AUTHORS, I. Skorniakov, D. Vikulova, C. Whiteley, O. Shaikh, A. Jones, M. Ostermann, L. Forni, M. Scott, J. Sahatjian, W. Linde-Zwirble, D. Hansell, P. Laoveeravat, N. Srisawat, M. Kongwibulwut, S. Peerapornrattana, N. Suwachittanont, T. O. Wirotwan, P. Chatkaew, P. Saeyub, K. Latthaprecha, K. Tiranathanagul, S. Eiam-ong, J. A. Kellum, R. E. Berthelsen, A. Perner, A. E. K. Jensen, J. U. Jensen, D. J. Gebhard, J. Price, C. E. Kennedy, A. Akcan-Arikan, Y. R. Kang, M. N. Nakamae, K. Hamed, M. M. Khaled, R. Aly Soliman, M. Sherif Mokhtar, G. Seller-Pérez, D. Arias-Verdú, E. Llopar-Valdor, I. De-Diós-Chacón, G. Quesada-García, M. E. Herrera-Gutierrez, R. Hafes, G. Carroll, P. Doherty, C. Wright, I. G. Guerra Vera, M. Ralston, M. L. Gemmell, A. MacKay, E. Black, R. I. Docking, R. Appleton, M. R. Ralston, L. Gemmell, A. Mackay, J. G. Röttgering, P. W. G. Elbers, N. Mejeni, J. Nsiala, A. Kilembe, P. Akilimali, G. Thomas, A. E. Andersson, A. M. Fagerdahl, V. Knudsen, P-INFECT, A. Ben Cheikh, Y. Hamdaoui, A. Guiga, N. Fraj, N. Sma, I. Chouchene, N. Bouafia, A. Amirian, B. Ziaian, C. Fleischmann, D. O. Thomas-Rueddel, A. Schettler, D. Schwarzkopf, A. Stacke, K. Reinhart, A. Martins, P. Sousa, G. Snell, R. Matsa, T. T. S. Paary, A. M. Cavalheiro, L. L. Rocha, C. S. Vallone, A. Tonilo, M. D. S. Lobato, D. T. Malheiro, G. Sussumo, N. M. Lucino, V. D. Rosenthal, A. Sanaei Dashti, A. Yousefipour, J. R. Goodall, M. Williamson, E. Tant, N. Thomas, C. Balci, C. Gonen, E. Haftacı, H. Gurarda, E. Karaca, B. Paldusová, I. Zýková, D. Šímová, S. Houston, L. D’Antona, J. Lloyd, V. Garnelo-Rey, M. Sosic, V. Sotosek-Tokmazic, J. Kuharic, I. Antoncic, S. Dunatov, A. Sustic, C. T. Chong, M. Sim, T. Lyovarin, F. M. Acosta Díaz, S. Narbona Galdó, M. Muñoz Garach, O. Moreno Romero, A. M. Pérez Bailón, A. Carranza Pinel, M. Colmenero, A. Gritsan, A. Gazenkampf, E. Korchagin, N. Dovbish, R. M. Lee, M. P. P. Lim, B. C. L. Lim, J. J. See, R. Assis, F. Filipe, N. Lopes, L. Pessoa, T. Pereira, N. Catorze, M. S. Aydogan, C. Aldasoro, P. Marchio, A. Jorda, M. D. Mauricio, S. Guerra-Ojeda, M. Gimeno-Raga, M. Colque-Cano, A. Bertomeu-Artecero, M. Aldasoro, S. L. Valles, D. Tonon, T. Triglia, J. C. Martin, M. C. Alessi, N. Bruder, P. Garrigue, L. Velly, S. Spina, V. Scaravilli, C. Marzorati, E. Colombo, D. Savo, A. Vargiolu, G. Cavenaghi, G. Citerio, A. H. V. Andrade, P. Bulgarelli, J. A. P. Araujo, V. Gonzalez, V. A. Souza, C. Massant, C. A. C. Abreu Filho, R. A. Morbeck, L. E. Burgo, R. van Groenendael, L. T. van Eijk, G. P. Leijte, B. Koeneman, M. Kox, P. Pickkers, A. García-de la Torre, M. de la Torre-Prados, A. Fernández-Porcel, C. Rueda-Molina, P. Nuevo-Ortega, T. Tsvetanova-Spasova, E. Cámara-Sola, A. García-Alcántara, L. Salido-Díaz, X. Liao, T. Feng, J. Zhang, X. Cao, Q. Wu, Z. Xie, H. Li, Y. Kang, M. S. Winkler, A. Nierhaus, E. Mudersbach, A. Bauer, L. Robbe, C. Zahrte, E. Schwedhelm, S. Kluge, C. Zöllner, E. Mitsi, S. H. Pennington, J. Reine, A. D. Wright, R. Parker, I. D. Welters, J. D. Blakey, G. Rajam, E. W. Ades, D. M. Ferreira, D. Wang, A. Kadioglu, S. B. Gordon, R. Koch, J. Rahamat-Langedoen, J. Schloesser, M. de Jonge, J. Bringue, R. Guillamat-Prats, E. Torrents, M. L. Martinez, M. Camprubí-Rimblas, L. Blanch, S. Y. Park, Y. B. Park, D. K. Song, S. Shrestha, S. H. Park, Y. Koh, M. J. Park, C. W. Hong, O. Lesur, D. Coquerel, X. Sainsily, J. Cote, T. Söllradl, A. Murza, L. Dumont, R. Dumaine, M. Grandbois, P. Sarret, E. Marsault, D. Salvail, M. Auger-Messier, F. Chagnon, Apelin Group, M. P. Lauretta, E. Greco, A. Dyson, S. Preau, M. Ambler, A. Sigurta, S. Saeed, L. Topcu Sarıca, N. Zibandeh, D. Genc, F. Gul, T. Akkoc, E. Kombak, L. Cinel, I. Cinel, S. J. Pollen, N. Arulkumaran, G. Warnes, D. J. Pennington, K. Brohi, M. J. O’Dwyer, H. Y. Kim, S. Na, J. Kim, Y. F. Chang, A. Chao, P. Y. Shih, C. T. Lee, Y. C. Yeh, L. W. Chen, M. Adriaanse, W. Rietdijk, S. Funcke, S. Sauerlaender, B. Saugel, H. Pinnschmidt, D. A. Reuter, R. Nitzschke, S. Perbet, C. Biboulet, A. Lenoire, D. Bourdeaux, B. Pereira, B. Plaud, J. E. Bazin, V. Sautou, A. Mebazaa, J. M. Constantin, M. Legrand, Y. Boyko, P. Jennum, M. Nikolic, H. Oerding, R. Holst, P. Toft, H. K. Nedergaard, T. Haberlandt, S. Park, S. Kim, Y. J. Cho, Y. J. Lim, A. Chan, S. Tang, S. L. Nunes, S. Forsberg, H. Blomqvist, L. Berggren, M. Sörberg, T. Sarapohja, C. J. Wickerts, J. G. M. Hofhuis, L. Rose, B. Blackwood, E. Akerman, J. Mcgaughey, M. Fossum, H. Foss, E. Georgiou, H. J. Graff, M. Kalafati, R. Sperlinga, A. Schafer, A. G. Wojnicka, P. E. Spronk, F. Khalili, R. Afshari, H. Haddad Khodaei, S. Javadpour, P. Petramfar, S. Nasimi, H. Tabei, A. Gunther, J. O. Hansen, P. Sackey, H. Storm, J. Bernhardsson, Ø. Sundin, A. Bjärtå, A. Bienert, P. Smuszkiewicz, P. Wiczling, K. Przybylowski, A. Borsuk, I. Trojanowska, J. Matysiak, Z. Kokot, M. Paterska, E. Grzeskowiak, A. Messina, E. Bonicolini, D. Colombo, G. Moro, S. Romagnoli, A. R. De Gaudio, F. Della Corte, S. M. Romano, J. A. Silversides, E. Major, E. E. Mann, A. J. Ferguson, D. F. Mcauley, J. C. Marshall, J. A. Diaz-Rodriguez, R. Silva-Medina, E. Gomez-Sandoval, N. Gomez-Gonzalez, R. Soriano-Orozco, P. L. Gonzalez-Carrillo, M. Hernández-Flores, K. Pilarczyk, J. Lubarksi, D. Wendt, F. Dusse, J. Günter, B. Huschens, E. Demircioglu, H. Jakob, A. Palmaccio, A. M. Dell’Anna, D. L. Grieco, F. Torrini, C. Iaquaniello, F. Bongiovanni, M. Antonelli, L. Toscani, D. Antonakaki, D. Bastoni, M. Jozwiak, F. Depret, J. L. Teboul, J. Alphonsine, C. Lai, C. Richard, X. Monnet, G. Demeter, I. Kertmegi, A. Hasanin, A. Lotfy, A. El-adawy, H. Nassar, S. Mahmoud, A. Abougabal, A. Mukhtar, F. Quinty, S. Habchi, A. Luzi, E. Antok, G. Hernandez, B. Lara, L. Enberg, M. Ortega, P. Leon, C. Kripper, P. Aguilera, E. Kattan, M. Lehmann, S. Sakka, B. Bein, R. M. Schmid, J. Preti, J. Creteur, A. Herpain, J. Marc, F. Trojette, S. Bar, L. Kontar, D. Titeca, J. Richecoeur, B. Gelee, N. Verrier, R. Mercier, E. Lorne, J. Maizel, M. Slama, M. E. Abdelfattah, A. Eladawy, M. A. Ali Elsayed, A. Pedraza Montenegro, E. Monares Zepeda, J. Franco Granillo, J. S. Aguirre Sánchez, G. Camarena Alejo, A. Rugerio Cabrera, A. A. Tanaka Montoya, C. Lee, F. Hatib, M. Cannesson, P. Theerawit, T. Morasert, Y. Sutherasan, G. Zani, S. Mescolini, M. Diamanti, R. Righetti, A. Scaramuzza, M. Papetti, M. Terenzoni, C. Gecele, M. Fusari, K. A. Hakim, A. Chaari, M. Ismail, A. H. Elsaka, T. M. Mahmoud, K. Bousselmi, V. Kauts, W. F. Casey, S. D. Hutchings, D. Naumann, J. Wendon, S. Watts, E. Kirkman, Z. Jian, S. Buddi, J. Settels, P. Bertini, F. Guarracino, C. Trepte, P. Richter, S. A. Haas, V. Eichhorn, J. C. Kubitz, M. S. Soliman, W. I. Hamimy, A. Z. Fouad, A. M. Mukhtar, M. Charlton, L. Tonks, L. Mclelland, T. J. Coats, J. P. Thompson, M. R. Sims, D. Williams, D. Z. Roushdy, R. A. Soliman, R. A. Nahas, M. Y. Arafa, W. T. Hung, C. C. Chiang, W. C. Huang, K. C. Lin, S. C. Lin, C. C. Cheng, P. L. Kang, S. R. Wann, G. Y. Mar, C. P. Liu, M. Lopez Carranza, H. Sancho Fernandez, J. A. Sanchez Roman, F. Lucena, A. Campanario Garcia, A. Loza Vazquez, A. Lesmes Serrano, ARIAM-SEMICYUC Registry Investigators, L. Sayagues Moreira, R. Vidal-Perez, U. Anido Herranz, J. M. Garcia Acuna, C. Pena Gil, J. L. Garcia Allut, P. Rascado Sedes, C. Martin Lopez, E. Saborido Paz, C. Galban Rodriguez, J. R. Gonzalez-Juanatey, A. Vallejo-Baez, M. V. de la Torre-Prados, ARIAM Group, R. Marharaj, K. Gervasio, M. Bottiroli, M. Mondino, D. De Caria, A. Calini, E. Montrasio, F. Milazzo, M. P. Gagliardone, A. Vallejo-Báez, ARIAM group, U. Anido, M. Cheikh-Bouhlel, M. P. R. D. L. Dela Cruz, J. M. Bernardo, F. Galfo, A. Marino, C. C. Chao, P. Hou, C. C. Hung, C. H. Chiang, Y. J. Liou, S. M. Hung, Y. S. Lin, F. Y. Kuo, K. R. Chiou, C. J. Chen, L. S. Yan, C. Y. Liu, H. H. Wang, H. L. Chen, C. K. Ho, S. Grewal, S. Gopal, C. Corbett, A. Wilson, J. Capps, W. Ayoub, A. Lomas, S. Ghani, J. Moore, D. Atkinson, M. Sharman, W. Swinnen, J. Pauwels, K. Mignolet, E. Pannier, A. Koch, T. Sarens, W. Temmerman, A. M. Elmenshawy, A. M. Fayed, M. Elboriuny, E. Hamdy, E. Zakaria, A. C. Falk, A. Petosic, K. Olafsen, H. Wøien, H. Flaatten, K. Sunde, J. J. Cáceres Agra, J. L. Santana Cabrera, J. D. Martín Santana, L. Melián Alzola, H. Rodríguez Pérez, T. Castro Pires, H. Calderón, A. Pereira, S. Castro, C. Granja, I. Norkiene, I. Urbanaviciute, G. Kezyte, D. Ringaitiene, T. Jovaisa, G. Vogel, U. B. Johansson, A. Sandgren, C. Svensen, E. Joelsson-Alm, M. A. Leite, L. D. Murbach, E. F. Osaku, C. R. L. M. Costa, M. Pelenz, N. M. Neitzke, M. M. Moraes, J. L. Jaskowiak, M. M. M. Silva, R. S. Zaponi, L. R. L. Abentroth, S. M. Ogasawara, A. C. Jorge, P. A. D. Duarte, J. Barreto, S. T. Duarte, S. Taba, D. Miglioranza, D. P. Gund, C. F. Lordani, H. Vollmer, M. Gager, C. Waldmann, A. T. Mazzeo, R. Tesio, C. Filippini, M. E. Vallero, C. Giolitti, S. Caccia, M. Medugno, T. Tenaglia, R. Rosato, I. Mastromauro, L. Brazzi, P. P. Terragni, R. Urbino, V. Fanelli, V. M. Ranieri, L. Mascia, J. Ballantyne, L. Paton, P. Perez-Teran, O. Roca, J. C. Ruiz-Rodriguez, A. Zapatero, J. Serra, S. Bianzina, P. Cornara, G. Rodi, G. Tavazzi, M. Pozzi, G. A. Iotti, F. Mojoli, A. Braschi, A. Vishnu, D. Buche, R. Pande, D. L. J. Moolenaar, F. Bakhshi-Raiez, D. A. Dongelmans, N. F. de Keizer, D. W. de Lange, I. Fuentes Fernández, D. Martínez Baño, J. L. Buendía Moreno, R. Jara Rubio, J. Scott, D. Phelan, D. Morely, J. O’Flynn, P. Stapleton, M. Lynch, B. Marsh, E. Carton, C. O’Loughlin, K. C. Cheng, M. I. Sung, M. O. Elghonemi, M. H. Saleh, T. S. Meyhoff, M. Krag, P. B. Hjortrup, M. H. Møller, T. Öhman, T. Sigmundsson, E. Redondo, M. Hallbäck, F. Suarez-Sipmann, H. Björne, C. Hällsjö Sander, KARISMA, D. Chiumello, C. Chiurazzi, M. Brioni, I. Algieri, M. Guanziroli, G. Vergani, T. Tonetti, I. Tomic, A. Colombo, F. Crimella, E. Carlesso, V. Gasparovic, R. El-Sherif, M. Abd Al-Basser, A. Raafat, A. El-Sherif, L. R. A. Schouten, O. L. Cremer, D. S. Y. Ong, G. Amoruso, G. Cinnella, L. D. J. Bos, P. Schmidle, M. Findeisen, P. Hoppmann, J. Jaitner, F. Brettner, T. Lahmer, EXODUS-investigators, G. Rajagopalan, V. Bansal, R. Frank, R. Hinds, J. Levitt, United States Critical Illness and Injury Trials Group/LIPS-B investigators, S. Siddiqui, SICM NICER Group, J. P. Gilbert, K. Sim, C. H. Wang, I. J. Li, W. R. Tang, P. Persona, A. De Cassai, M. Franco, A. Goffi, B. Llorente Ruiz, J. Lujan Varas, R. Molina Montero, C. Pintado Delgado, O. Navarrete, M. Vazquez Mezquita, E. Alonso Peces, M. A. M. Nakamura, L. A. Hajjar, F. R. B. G. Galas, T. A. Ortiz, M. B. P. Amato, L. Bitker, N. Costes, D. Le Bars, F. Lavenne, D. Mojgan, J. C. Richard, D. Massari, M. Gotti, P. Cadringher, A. Zerman, M. Türkoğlu, G. Arık, F. Yıldırım, Z. Güllü, I. Kara, N. Boyacı, B. Basarık Aydoğan, Ü. Gaygısız, K. Gönderen, G. Aygencel, M. Aydoğdu, Z. Ülger, G. Gürsel, J. Riera, C. Maldonado Toral, C. Mazo, M. Martínez, J. Baldirà, L. Lagunes, A. Roman, M. Deu, J. Rello, D. J. Levine, R. M. Mohus, Å. Askim, J. Paulsen, A. Mehl, A. T. Dewan, J. K. Damås, E. Solligård, B. O. Åsvold, Mid-Norway Sepsis Research Center, A. DeWan, O. Aktepe, A. Kara, H. Yeter, A. Topeli, M. Norrenberg, M. Devroey, H. Khader, J. C. Preiser, Z. Tang, C. Qiu, L. Tong, C. Cai, O. Apostolopoulou, J. Y. Moon, M. R. Park, I. S. Kwon, G. R. Chon, J. Y. Ahn, S. J. Kwon, Y. J. Chang, J. Y. Lee, S. Y. Yoon, J. W. Lee, The Korean Chungcheong Critical Care Research Group, M. Kostalas, J. Mckinlay, G. Kooner, G. Dudas, A. Horton, C. Kerr, N. Karanjia, B. Creagh-Brown, N. D. Altintas, S. Izdes, O. Keremoglu, A. Alkan, S. Neselioglu, O. Erel, N. Tardif, T. Gustafsson, K. N. MacEachern, M. Traille, I. Bromberg, S. E. Lapinsky, M. J. Moore, J. L. García-Garmendia, F. Villarrasa-Clemente, F. Maroto-Monserrat, O. Rufo-Tejeiro, V. Jorge-Amigo, M. Sánchez-Santamaría, C. Colón-Pallarés, A. Barrero-Almodóvar, S. Gallego-Lara, C. T. Anthon, R. B. Müller, N. Haase, K. Møller, J. Wetterslev, M. Nakanishi, A. Kuriyama, T. Fukuoka, M. A. Abd el Halim, M. H. Elsaid hafez, A. M. Moktar, H. M. Elazizy, K. Abdel Hakim, M. Elbahr, T. Mahmoud, E. Khalil, W. Casey, S. H. Zaky, A. Rizk, R. Ahmed, G. A. Ospina-Tascón, A. F. Garcia Marin, G. J. Echeverry, W. F. Bermudez, H. J. Madriñan-Navia, J. D. Valencia, E. Quiñonez, A. Marulanda, C. A. Arango-Dávila, A. Bruhn, D. De Backer, D. Orbegozo Cortes, F. Su, J. L. Vincent, L. Tullo, L. Mirabella, P. Di Molfetta, M. Dambrosio, C. Villavicencio Lujan, J. Leache irigoyen, M. Cartanya ferré, R. Carbonell García, M. Ahmed, M. El Ayashi, E. Ayman, M. Salem, S. Fathy, A. Zaghlol, M. F. Aguilar Arzapalo, Å. Valsø, T. Rustøen, I. Schou-Bredal, L. Skogstad, K. Tøien, C. Padilla, Y. Palmeiro, W. Egbaria, R. Kigli, B. Maertens, K. Blot, S. Blot, E. Santana-Santos, E. R. dos Santos, R. E. D. L. Ferretti-Rebustini, R. D. C. C. D. O. dos Santos, R. G. S. Verardino, L. A. Bortolotto, A. M. Doyle, I. Naldrett, J. Tillman, S. Price, P. Pearson, J. Greaves, D. Goodall, A. Berry, A. Richardson, G. O. Odundo, P. Omengo, P. Obonyo, N. M. Chanzu, R. Kleinpell, S. J. Sarris, P. Nedved, M. Heitschmidt, H. Ben-Ghezala, S. Snouda, S. Djobbi, N. K. J. Adhikari, D. Leasa, D. Fergusson, D. A. Mckim, J. Weblin, D. McWilliams, F. Doesburg, F. Cnossen, W. Dieperink, W. Bult, M. W. N. Nijsten, G. A. Galvez-Blanco, C. I. Olvera Guzman, J. Santos Stroud, R. Thomson, M. Llaurado-Serra, A. Lobo-Civico, M. Pi-Guerrero, I. Blanco-Sanchez, A. Piñol-Tena, C. Paños-Espinosa, Y. Alabart-Segura, B. Coloma-Gomez, A. Fernandez-Blanco, F. Braga-Dias, M. Treso-Geira, A. Valeiras-Valero, L. Martinez-Reyes, A. Sandiumenge, M. F. Jimenez-Herrera, CAPCRI Study, R. Prada, P. Juárez, R. Argandoña, J. J. Díaz, C. Sánchez Ramirez, P. Saavedra, S. Ruiz Santana, O. Obukhova, S. Kashiya, I. A. Kurmukov, A. M. Pronina, P. Simeone, L. Puybasset, G. Auzias, O. Coulon, B. Lesimple, G. Torkomian, A. Bartkowska-Sniatkowska, O. Szerkus, D. Siluk, J. Bartkowiak-Wieczorek, J. Rosada-Kurasinska, J. Warzybok, R. Kaliszan, C. Hernandez Caballero, S. Roberts, G. Isgro, D. Hall, G. Guillaume, O. Passouant, F. Dumas, W. Bougouin, B. Champigneulle, M. Arnaout, J. Chelly, J. D. Chiche, O. Varenne, J. P. Mira, E. Marijon, A. Cariou, M. Beerepoot, H. R. Touw, K. Parlevliet, C. Boer, P. W. Elbers, Á. J. Roldán Reina, Y. Corcia Palomo, R. Martín Bermúdez, L. Martín Villén, I. Palacios García, J. R. Naranjo Izurieta, J. B. Pérez Bernal, F. J. Jiménez Jiménez, Cardiac Arrest Group HUVR, F. Cota-Delgado, T. Kaneko, H. Tanaka, M. Kamikawa, R. Karashima, S. Iwashita, H. Irie, S. Kasaoka, O. Arola, R. Laitio, A. Saraste, J. Airaksinen, M. Pietilä, M. Hynninen, J. Wennervirta, M. Bäcklund, E. Ylikoski, P. Silvasti, E. Nukarinen, J. Grönlund, V. P. Harjola, J. Niiranen, K. Korpi, M. Varpula, R. O. Roine, T. Laitio, for the Xe-HYPOTHECA study group, S. Salah, B. G. Hassen, A. Mohamed Fehmi, Y. C. Hsu, J. Barea-Mendoza, C. García-Fuentes, M. Castillo-Jaramillo, H. Dominguez-Aguado, R. Viejo-Moreno, L. Terceros-Almanza, S. Bermejo Aznárez, C. Mudarra-Reche, W. Xu, M. Chico-Fernández, J. C. Montejo-González, K. Crewdson, M. Thomas, M. Merghani, L. Fenner, P. Morgan, D. Lockey, E. J. van Lieshout, B. Oomen, J. M. Binnekade, R. J. de Haan, N. P. Juffermans, M. B. Vroom, R. Algarte, L. Martínez, B. Sánchez, I. Romero, F. Martínez, S. Quintana, J. Trenado, O. Sheikh, D. Pogson, R. Clinton, F. Riccio, A. Arthur, L. Young, A. Sinclair, D. Markopoulou, K. Venetsanou, L. Filippou, E. Salla, S. Stratouli, I. Alamanos, A. H. Guirgis, R. Gutiérrez Rodriguez, M. J. Furones Lorente, I. Macias Guarasa, A. Ukere, S. Meisner, G. Greiwe, B. Opitz, D. Benten, B. Nashan, L. Fischer, C. J. C. Trepte, C. R. Behem, B. Ana, A. Vazir, D. Gibson, M. R. Hadavi, M. Riahi alam, M. R. Sasani, N. Parenti, F. Agrusta, C. Palazzi, B. Pifferi, R. Sganzerla, F. Tagliazucchi, A. Luciani, M. Möller, J. Müller-Engelmann, G. Montag, P. Adams, C. Lange, J. Neuzner, R. Gradaus, K. H. Wodack, F. Thürk, A. D. Waldmann, M. F. Grässler, S. Nishimoto, S. H. Böhm, E. Kaniusas, C. J. Trepte, M. Wallin, F. Suarez Sipman, A. Oldner, L. Colinas, R. Vicho, M. Serna, R. Cuena, A. Canabal, ECOCRITIC group, M. Etman, M. El Bahr, A. El Sakka, A. Arali, O. Bond, P. De Santis, E. Iesu, F. Franchi, S. Scolletta, F. S. Taccone, Z. Marutyan, L. Hamidova, A. Shakotko, V. Movsisyan, I. Uysupova, A. Evdokimov, S. Petrikov, F. J. Redondo Calvo, N. Bejarano, V. Baladron, R. Villazala, J. Redondo, D. Padilla, P. Villarejo, C. Gomez-Gonzalez, S. Mas-Font, A. Puppo-Moreno, M. Herrera-Gutierrez, M. Garcia-Garcia, S. Aldunate-Calvo, NEFROCON Investigators, E. P. Plata-Menchaca, X. L. Pérez-Fernández, M. Estruch, A. Betbese-Roig, P. Cárdenas Campos, M. Rojas Lora, N. D. Toapanta Gaibor, R. S. Contreras Medina, V. D. Gumucio Sanguino, E. J. Casanova, J. Sabater Riera, SIRAKI group, K. Kritmetapak, S. Peerapornratana, P. Kittiskulnam, T. Dissayabutra, P. Susantithapong, K. Praditpornsilpa, K. Tungsanga, S. Eiam-Ong, T. Winkelmann, T. Busch, J. Meixensberger, S. Bercker, E. M. Flores Cabeza, M. Sánchez Sánchez, N. Cáceres Giménez, C. Gutierrez Melón, E. Herrero de Lucas, P. Millán Estañ, M. Hernández Bernal, A. Garcia de Lorenzo y Mateos, P. A. C. Specht, M. Balik, M. Zakharchenko, F. Los, H. Brodska, C. de Tymowski, P. Augustin, M. Desmard, P. Montravers, S. N. Stapel, R. de Boer, H. M. Oudemans, A. Hollinger, T. Schweingruber, F. Jockers, M. Dickenmann, M. Siegemund, Clinical Intensive Care Research Basel, N. Runciman, L. Alban, C. Turrini, T. Sasso, T. Langer, P. Taccone, C. Marenghi, G. Grasselli, P. Wibart, T. Reginault, M. Garcia, B. Barbrel, A. Benard, C. Bader, F. Vargas, H. N. Bui, G. Hilbert, J. M. Serrano Simón, P. Carmona Sánchez, F. Ruiz Ferrón, M. García de Acilu, J. Marin, V. Antonia, L. Ruano, M. Monica, G. Hong, D. H. Kim, Y. S. Kim, J. S. Park, Y. K. Jee, Z. Yu xiang, W. Jia-xing, W. Xiao dan, N. Wen long, W. Yu, Z. Yan, X. Cheng, T. Kobayashi, Y. Onodera, R. Akimoto, A. Sugiura, H. Suzuki, M. Iwabuchi, M. Nakane, K. Kawamae, P. Carmona Sanchez, M. D. Bautista Rodriguez, M. Rodriguez Delgado, V. Martínez de Pinillos Sánchez, A. Mula Gómez, P. Beuret, C. Fortes, M. Lauer, M. Reboul, J. C. Chakarian, X. Fabre, B. Philippon-Jouve, S. Devillez, M. Clerc, N. Rittayamai, M. Sklar, M. Dres, M. Rauseo, C. Campbell, B. West, D. E. Tullis, M. Okada, N. Ahmad, M. Wood, A. Glossop, J. Higuera Lucas, A. Blandino Ortiz, D. Cabestrero Alonso, R. De Pablo Sánchez, L. Rey González, R. Costa, G. Spinazzola, A. Pizza, G. Ferrone, M. Rossi, G. Conti, H. Ribeiro, J. Alves, M. Sousa, P. Reis, C. S. Socolovsky, R. P. Cauley, J. E. Frankel, A. L. Beam, K. O. Olaniran, F. K. Gibbons, K. B. Christopher, J. Pennington, P. Zolfaghari, H. S. King, H. H. Y. Kong, H. P. Shum, W. W. Yan, C. Kaymak, N. Okumus, A. Sari, B. Erdogdu, S. Aksun, H. Basar, A. Ozcan, N. Ozcan, D. Oztuna, J. A. Malmgren, S. Lundin, K. Torén, M. Eckerström, A. Wallin, A. C. Waldenström, for the Section on Ethics of the ESICM, F. C. Riccio, A. C. P. Antonio, A. F. Leivas, F. Kenji, E. James, S. Jonnada, C. S. Gerrard, N. Jones, J. D. Salciccioli, D. C. Marshall, M. Komorowski, A. Hartley, M. C. Sykes, R. Goodson, J. Shalhoub, J. R. Fernández Villanueva, R. Fernández Garda, A. M. López Lago, E. Rodríguez Ruiz, R. Hernández Vaquero, C. Galbán Rodríguez, E. Varo Pérez, C. Hilasque, I. Oliva, G. Sirgo, M. C. Martin, M. Olona, M. C. Gilavert, M. Bodí, C. Ebm, G. Aggarwal, S. Huddart, N. Quiney, S. M. Fernandes, J. Santos Silva, J. Gouveia, D. Silva, R. Marques, H. Bento, A. Alvarez, Z. Costa Silva, D. Díaz Diaz, M. Villanova Martínez, E. Palencia Herrejon, A. Martinez de la Gandara, G. Gonzalo, M. A. Lopez, P. Ruíz de Gopegui Miguelena, C. I. Bernal Matilla, P. Sánchez Chueca, M. D. C. Rodríguez Longares, R. Ramos Abril, A. L. Ruíz Aguilar, R. Garrido López de Murillas, R. Fernández Fernández, P. Morales Laborías, M. A. Díaz Castellanos, M. E. Morales Laborías, J. Park, S. Woo, T. West, E. Powell, A. Rimmer, C. Orford, J. Williams, P. Ruiz de Gopegui Miguelena, R. S. Bourne, R. Shulman, M. Tomlin, G. H. Mills, M. Borthwick, W. Berry, D. García Huertas, F. Manzano, F. Villagrán-Ramírez, A. Ruiz-Perea, C. Rodríguez-Mejías, F. Santiago-Ruiz, M. Colmenero-Ruiz, C. König, B. Matt, A. Kortgen, C. S. Hartog, A. Wong, C. Balan, G. Barker, S. Tachaboon, J. Paratz, G. Kayambu, R. Boots, R. Vlasenko, E. Gromova, S. Loginov, M. Kiselevskiy, Y. Dolgikova, K. B. Tang, C. M. Chau, K. N. Lam, E. Gil, G. Y. Suh, C. M. Park, C. R. Chung, C. H. Lai, Y. J. Cheng, V. Colella, N. Zarrillo, M. D’Amico, F. Forfori, B. Pezza, T. Laddomada, V. Beltramelli, M. L. Pizzaballa, A. Doronzio, B. Balicco, D. Kiers, W. van der Heijden, J. Gerretsen, Q. de Mast, S. el Messaoudi, G. Rongen, M. Gomes, N. P. Riksen, Y. Kashiwagi, K. Hayashi, Y. Inagaki, S. Fujita, A. Blet, M. Sadoune, J. Lemarié, N. Bihry, R. Bern, E. Polidano, R. Merval, J. M. Launay, B. Lévy, J. L. Samuel, J. Hartmann, S. Harm, and V. Weber
- Subjects
Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Published
- 2016
- Full Text
- View/download PDF
3. Implementation of a major trauma team. Analysis of activation and care times in patients admitted to the ICU
- Author
-
N, Montserrat Ortiz, J, Trujillano Cabello, M, Badia Castelló, J, Vilanova Corsellas, G, Jimenez Jimenez, J, Rubio Ruiz, A, Pujol Freire, D, Morales Hernandez, and L, Servia Goixart
- Abstract
To analyze the factors associated with the activation of the severe trauma care team (STAT) in patients admitted to the ICU, to measure its impact on care times, and to analyze the groups of patients according to activation and level of anatomical involvement.Prospective cohort study of severe trauma admitted to the ICU. From June 2017 to May 2019. Risk factors for the activation of the STAT analysed with logistic regression and CART type classification tree.Second level hospital ICU.Patients admitted consecutively.No.STAT activation. Demographic variables. Injury severity (ISS), intentionality, mechanism, assistance times, evolutionary complications, and mortality.A total of 188 patients were admitted (46.8% of STAT activation), median age of 52 (37-64) years (activated 47 (27-62) vs not activated 55 (42-67) P = 0.023), males 84.0%. No difference in mortality according to activation. The logistic model finds as factors: care (16.6 (2.1-13.2)) and prehospital intubation (4.2 (1.8-9.8)) and severe lower extremity injury (4.4 (1.6-12.3)). Accidental fall (0.2 (0.1-0.6)) makes activation less likely. The CART model selects the type of trauma mechanism and can separate high and low energy trauma.Factors associated with STAT activation were prehospital care, requiring prior intubation, high-energy mechanisms, and severe lower extremity injuries. Shorter care times if activated without influencing mortality. We must improve activation in older patients with low-energy trauma and without prehospital care.
- Published
- 2022
4. Behavior and complications of hyperglycemia in critical care patients
- Author
-
L. Macaya Redín, E. Mor-Marco, R. Iglesias-Rodriguez, J. Gonzalez Londoño, E. Portugal-Rodriguez, J. Marin Corral, J.C. Lopez-Delgado, T. Grau-Carmona, J. Martínez Carmona, J. Trujillano Cabello, D. Monge-Donaire, C. Lorencio, L. Bordejé, L. Servià Goixart, B. Llorente-Ruiz, and P. Vera-Artazcoz
- Subjects
medicine.medical_specialty ,Nutrition and Dietetics ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine ,Intensive care medicine ,business - Published
- 2021
5. Glycemic variability in critical care patients with artificial nutrition
- Author
-
R. Iglesias-Rodriguez, C. Lorencio, J. Trujillano Cabello, L. Macaya Redín, T. Grau-Carmona, J. Marin Corral, J. Gonzalez Londoño, J. Martínez Carmona, D. Monge-Donaire, L. Bordejé, E. Mor-Marco, L. Servià Goixart, J.C. Lopez-Delgado, E. Portugal-Rodriguez, B. Llorente-Ruiz, and P. Vera-Artazcoz
- Subjects
medicine.medical_specialty ,Nutrition and Dietetics ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine ,Artificial nutrition ,Intensive care medicine ,business ,Glycemic - Published
- 2021
6. Survey on the assessment of nutritional status and feedback syndrome in Spanish intensive care units
- Author
-
J. Trujillano Cabello, M. Zamora Elson, C. González Iglesias, M.L. Bordejé Laguna, J.F. Fernández Ortega, and C. Vaquerizo Alonso
- Subjects
medicine.medical_specialty ,Phosphorus blood ,Nutrition assessment ,business.industry ,Intensive care ,Family medicine ,Severity of illness ,MEDLINE ,Medicine ,Nutritional status ,Medical prescription ,business - Published
- 2018
7. Encuesta sobre valoración del estado nutricional y síndrome de realimentación en las unidades de cuidados intensivos en España
- Author
-
J.F. Fernández Ortega, J. Trujillano Cabello, C. González Iglesias, M.L. Bordejé Laguna, M. Zamora Elson, and C. Vaquerizo Alonso
- Subjects
03 medical and health sciences ,0302 clinical medicine ,business.industry ,Medicine ,030208 emergency & critical care medicine ,030212 general & internal medicine ,Critical Care and Intensive Care Medicine ,business ,Humanities - Published
- 2018
8. Survey on the assessment of nutritional status and feedback syndrome in Spanish intensive care units
- Author
-
M, Zamora Elson, J, Trujillano Cabello, C, González Iglesias, M L, Bordejé Laguna, J F, Fernández Ortega, and C, Vaquerizo Alonso
- Subjects
Risk ,Critical Care ,Malnutrition ,Water-Electrolyte Imbalance ,Nutritional Status ,Phosphorus ,Nutrition Surveys ,Severity of Illness Index ,Intensive Care Units ,Nutrition Assessment ,Prescriptions ,Risk Factors ,Spain ,Humans ,Refeeding Syndrome ,Societies, Medical - Published
- 2017
9. Factores de riesgo de deterioro de calidad de vida en pacientes traumáticos críticos. Valoración a los 6 y 12 meses del alta de la unidad de cuidados intensivos
- Author
-
J. Trujillano Cabello, J. Vilanova Corselles, E. Vicario Izquierdo, L. Servià Goixart, G. Bello Rodriguez, N. Montserrat Ortiz, and M. Badia Castelló
- Subjects
business.industry ,Medicine ,Critical Care and Intensive Care Medicine ,business ,Humanities - Abstract
Resumen Objetivo Evaluar los factores que influyen en el deterioro de la calidad de vida relacionada con la salud (CVRS) de pacientes traumatizados ingresados en una UCI. Diseno Estudio prospectivo observacional. Ambito UCI polivalente de un hospital universitario de segundo nivel con servicio de neurocirugia 24 h. Pacientes Pacientes traumatizados ingresados en la UCI durante un periodo de 2 anos. Evaluacion de CVRS previa, a los 6 y 12 meses del alta. Variables de interes Se recogen variables demograficas, tipo y gravedad de lesiones (AIS), nivel de gravedad (APACHE II, ISS, TRISS), estancia, procedimientos, mortalidad y CVRS segun los cuestionarios SF-36 y EQ-5D. Resultados Se completo el seguimiento en 110 pacientes que mostraron un deterioro significativo de su CVRS en todas las dimensiones evaluadas. Segun el SF-36 se deterioro mas el rol fisico a los 12 meses, aunque el componente mental disminuyo mas que el componente fisico a los 6 meses. La EVA del EQ-5D bajo a los 6 meses hasta 55 (19) y aumento a los 12 meses hasta 66 (17). En el analisis de regresion logistica multiple las variables relacionadas con peor CVRS fueron: la edad > 45 anos, un TRISS > 10, peor calidad de vida previa y tener una lesion grave de las extremidades. Conclusiones Los pacientes muestran un deterioro marcado de su CVRS a los 6 meses con mejoria a los 12 meses, aunque sin llegar a igualar su estado previo. Los factores que determinan peor calidad de vida son la edad, la gravedad, la CVRS previa y las lesiones graves de las extremidades.
- Published
- 2014
10. P1.03-43 Preoperative Prognostic Value of Immune-Inflammation Index in Patients with Operable Non-Small Cell Lung Cancer
- Author
-
C. Cerdan Santacruz, C. Fraile Olivero, C. Rombolá, M. Montesinos, L. Milla Collado, M. Mecho Carratala, A. Ojanguren Arranz, and J. Trujillano Cabello
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Index (economics) ,business.industry ,medicine.disease ,Internal medicine ,Medicine ,In patient ,Non small cell ,business ,Lung cancer ,Value (mathematics) ,Immune inflammation - Published
- 2019
11. EP1.03-04 Analysis of Post-Surgical Systemic Inflammatory Indexes After Non-Small Cell Lung Cancer Surgical Intervention
- Author
-
C. Fraile Olivero, M. Mecho Carratala, C. Cerdan Santacruz, L. Milla Collado, J. Trujillano Cabello, A. Ojanguren Arranz, C. Rombolá, and M. Montesinos
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Post surgical ,Oncology ,business.industry ,Internal medicine ,Intervention (counseling) ,medicine ,Non small cell ,business ,Lung cancer ,medicine.disease - Published
- 2019
12. Analysis of the analgesic therapeutic profile needed to achieve an optimal pain control in a sample of advanced cancer population: Experience from an out-patient clinic in a catalan teaching hospital
- Author
-
J. Canal-Sotelo, N. Arraras-Torrelles, J. Lopez-Ribes, R. Gonzalez-Rubio, E. Barallat-Gimeno, and J. Trujillano-Cabello
- Subjects
medicine.medical_specialty ,education.field_of_study ,business.industry ,Population ,Analgesic ,Sample (statistics) ,Out patient clinic ,Advanced cancer ,language.human_language ,Teaching hospital ,Anesthesiology and Pain Medicine ,Neurology ,Pain control ,Physical therapy ,medicine ,language ,Catalan ,Neurology (clinical) ,education ,business - Published
- 2018
13. Profile of the pharmacological approach needed in order to achieve the best pain control in a population of advanced cancer patients
- Author
-
N. Arraras-Torrelles, R. Gonzalez-Rubio, J. Lopez-Ribes, E. Barallat-Gimeno, J. Trujillano-Cabello, and J. Canal-Sotelo
- Subjects
medicine.medical_specialty ,education.field_of_study ,business.industry ,Population ,Advanced cancer ,Anesthesiology and Pain Medicine ,Neurology ,Pain control ,Order (business) ,medicine ,Neurology (clinical) ,Intensive care medicine ,education ,business - Published
- 2018
14. Cambios en la calidad de vida tras UCI según grupo diagnóstico. Comparación de dos instrumentos de medida
- Author
-
J. Trujillano Cabello, J. Marcha Llanes, M. Badia Castelló, L. Servià Goixart, and A. Rodríguez-Pozo
- Subjects
business.industry ,Medicine ,Critical Care and Intensive Care Medicine ,business ,Humanities - Abstract
Objetivo Analisis de la calidad de vida relacionada con la salud (CVRS). Se evaluan los cambios en la CVRS previa al ingreso en la Unidad de Cuidados Intensivos (UCI) y a los 12 meses del alta segun la categoria diagnostica, asi como la relacion entre ambos instrumentos de medida. Diseno Estudio prospectivo observacional. Ambito UCI polivalente de un Hospital Universitario de segundo nivel con 450 camas. Pacientes Pacientes ingresados en la UCI mas de 24 horas, durante un periodo de 18 meses. Variables de interes Se recogen variables demograficas, diagnostico al ingreso, nivel de gravedad (APACHE II), estancia, procedimientos, mortalidad y CVRS mediante los cuestionarios Short Form SF-36 (SF-36) y EuroQoL 5D (EQ-5D). El estado de salud previo al ingreso se evaluo de forma retrospectiva. Resultados Un total de 189 pacientes responden ambos cuestionarios. La calidad de vida mostro un deterioro significativo a los 12 meses del alta de la UCI. Los pacientes con traumatismo craneoencefalico (TCE) y neurologicos se asociaron con peor CVRS al ano del alta. Los pacientes con politrauma presentaron importantes limitaciones fisicas y dolor, pero sin diferencias significativas en el aspecto emocional. La EQ escala visual analogica y el EQ tarifa mostraron en estos tres grupos una diferencia clinicamente relevante. Los pacientes con problemas respiratorios representaron el unico grupo de pacientes que mejoro su CVRS. La comparacion entre ambos instrumentos de medida demostro una fuerte correlacion en la funcion fisica. En el aspecto emocional la correlacion fue mas debil. Conclusiones La valoracion de la CVRS en los pacientes ingresados en la UCI debe hacerse teniendo en cuenta la categoria diagnostica. Ambos instrumentos (EQ-5D y SF-36) son capaces de detectar los cambios en la CVRS, y a pesar de algunas diferencias en estructura y contenido miden aspectos similares de la calidad de vida.
- Published
- 2008
15. Characteristics of isolated multiresistant bacteria according germ, location and 'zero resistance' criteria
- Author
-
G Jimenez Jimenez, F. Barcenilla Gaite, M. Miralbés Torner, M. Vallverdú Vidal, B Balsera Garrido, J. Trujillano Cabello, R Gavilan Rabell, S Carvalho Brugger, M. Palomar Martínez, and S. Iglesias Moles
- Subjects
medicine.medical_specialty ,business.industry ,Critically ill ,Multiresistant bacteria ,Critical Care and Intensive Care Medicine ,Intensive care unit ,Checklist ,law.invention ,law ,Zero resistance ,Poster Presentation ,Medicine ,Colonization ,business ,Intensive care medicine - Abstract
Multiresistant bacteria (MRB) development is a growing phenomenon. In 2013, the “Zero Resistance” (RZ) program was launched in Spain, to help prevent the emergence of multiresistant bacteria (MRB) in critically ill patients. One of its recommendations is to complete a checklist upon patient admission in Intensive Care Unit (ICU) to identify those patients at high risk for colonization or infection by MRB*.
- Published
- 2015
16. Risk factors for colonization and infection by multiresistant bacteria
- Author
-
M. Miralbés Torner, G Jimenez Jimenez, M. Vallverdú Vidal, M. Palomar Martínez, R Gavilan Rabell, S Carvalho Brugger, F. Barcenilla Gaite, S. Iglesias Moles, B Balsera Garrido, and J. Trujillano Cabello
- Subjects
medicine.medical_specialty ,Critically ill ,business.industry ,Multiresistant bacteria ,Critical Care and Intensive Care Medicine ,Intensive care unit ,Checklist ,law.invention ,law ,Zero resistance ,Poster Presentation ,medicine ,Colonization ,Intensive care medicine ,business - Abstract
In 2013, the “Zero Resistance” (RZ) program was launched in Spain, to help prevent the emergence of multiresistant bacteria (MRB) in critically ill patients. One of its recommendations is to complete a checklist upon patient admission in Intensive Care Unit (ICU) to identify those patients at high risk for colonization or infection by MRB*.
- Published
- 2015
17. Redes neuronales artificiales en Medicina Intensiva. Ejemplo de aplicación con las variables del MPM II
- Author
-
J. March Llanes, M. Badia Castello, J. Trujillano Cabello, Y. A. Sorribas Tello, L. Servià Goixart, and A. Rodriguez Pozo
- Subjects
business.industry ,Medicine ,Critical Care and Intensive Care Medicine ,business ,Humanities - Abstract
Objetivo La aplicacion del indice de gravedad Mortality Probability Model (MPM II) en nuestra Unidad de Cuidados Intensivos (UCI) nos muestra una mala calibracion que nos obliga a buscar modelos reajustados. Diseno Para el reajuste de los modelos utilizamos tecnicas basadas en regresion logistica (RL) y una red neuronal artificial (RN) (perceptron multicapa con retropropagacion del error). Para valorar estos modelos utilizamos un grupo de 964 pacientes que se dividen en un grupo de Desarrollo (736 pacientes) y un grupo de Validacion (228). Se calcula el modelo MPM II Admision y a las 24-horas (MPM II-0 y MPM II-24), los modelos reajustados por RL (RLR-0 y RLR-24) y los obtenidos por las RN (RN-0 y RN-24). Los modelos desarrollados se contrastan en el grupo de Validacion evaluando sus propiedades de discriminacion con el area bajo la curva ROC (ABC [IC 95 %]) y su calibracion con el test de Hosmer-Lemeshow C (HLC [p]). Resultados Los modelos MPM II-0 y MPM-24 obtienen una buena discriminacion (ABC > 0,8) con pobre calibracion (HLC > 25). Los modelos reajustados (RLR y RN) mejoran en calibracion manteniendo una aceptable discriminacion. La RN es mejor en discriminacion (ABC = 0,85 [0,79-0,90]) y calibracion (HLC = 21 [p = 0,005]) en el modelo 24-horas, pero sin alcanzar significacion. Conclusion Una RN es capaz de estratificar el riesgo de mortalidad hospitalaria utilizando las variables del sistema MPM II. En el mismo grupo de pacientes la RN obtiene diferentes probabilidades de muerte. Esto se asocia con una contribucion diferente de las variables en los modelos basados en RL o RN.
- Published
- 2005
18. Impacto de la incorporación del servicio de neurocirugía en la unidad de cuidados intensivos de un hospital de segundo nivel
- Author
-
L. Servià Goixart, J. March Llanes, A. Rodriguez Pozo, J. Trujillano Cabello, and M. Badia Castelló
- Subjects
business.industry ,Medicine ,Critical Care and Intensive Care Medicine ,business ,Humanities - Abstract
Fundamento Evaluar el impacto en la demografia y case-mix de la incorporacion de los pacientes neuroquirurgicos a la unidad de cuidados intensivos de un hospital de segundo nivel. Pacientes y metodo Utilizacion de la base de datos de la unidad de cuidados intensivos polivalente. Los anos 1999-2000 (445 ingresos) sirven para establecer las previsiones y determinar las caracteristicas de nuestra unidad, y el ano 2001 (287 ingresos), con el servicio de neurocirugia incorporado, para la evaluacion. Se recogen de forma prospectiva las siguientes variables: edad, sexo, diagnostico en el momento del ingreso, evolucion, indice de gravedad (APACHE II, SAPS II y MPM II 0-24) y mortalidad. Resultados En el ano 2001 se incorporo a 80 pacientes con la nueva enfermedad a esta unidad de cuidados intensivos. De ellos, 49 eran pacientes neurotraumaticos, con una edad media de 36 (DE = 19) anos, un 88% de varones y una mortalidad del 24%. Trece tenian una enfermedad vascular neuroquirurgica, con una edad media de 64 (17) anos y una mortalidad del 77%. Un total de 16 pacientes fueron incluidos en el grupo de neuroquirurgicos programados y 2 en el grupo de otros. Frente al periodo 1999-2000, el ano 2001 presento un aumento de los pacientes quirurgicos, traumaticos y neurologicos, con una disminucion de los respiratorios. La media de pacientes con ventilacion mecanica paso del 59 al 63% y la mortalidad se redujo del 36 al 30%. La estancia en la unidad de cuidados intensivos paso de 9 (12) a 12 (17) dias. Las propiedades de discriminacion y calibracion de los scores han mejorado. Conclusiones La incorporacion de una nueva especialidad debe basarse en un aspecto dinamico, por lo que la evaluacion de este primer ano es importante. Se plantea la necesidad de una unidad de intermedios (para reducir la estancia). El desplazamiento de otros grupos diagnosticos (unidades de cuidados intensivos con problemas de falta de camas) debe tenerse en cuenta.
- Published
- 2003
19. (417) The use of the Edmonton Classification system for Cancer Pain adds clinical complexity to the Breakthrough Cancer Pain assessment
- Author
-
J. Canal-Sotelo, E. Barallat-Gimeno, J. Trujillano-Cabello, N. Arraras-Torrelles, R. Gonzalez-Rubio, and J. Lopez-Ribes
- Subjects
medicine.medical_specialty ,Anesthesiology and Pain Medicine ,Neurology ,business.industry ,Alternative medicine ,medicine ,Physical therapy ,Neurology (clinical) ,business ,Cancer pain - Published
- 2017
20. (415) Clinical outcomes related to the level of nicotine addiction in a population of advanced cancer patients
- Author
-
N. Arraras-Torrelles, R. Gonzalez-Rubio, J. Canal-Sotelo, E. Barallat-Gimeno, J. Trujillano-Cabello, and J. Lopez-Ribes
- Subjects
education.field_of_study ,medicine.medical_specialty ,Anesthesiology and Pain Medicine ,Neurology ,business.industry ,Population ,Medicine ,Neurology (clinical) ,business ,education ,Psychiatry ,Advanced cancer ,Nicotine Addiction - Published
- 2017
21. (198) Translation and validation of the Quick Users Guide of the Edmonton Classification System for Cancer Pain into Catalan and Spanish
- Author
-
J. Lopez-Ribes, C. Nekolaichuck, J. Canal-Sotelo, N. Arraras-Torrelles, R. Gonzalez-Rubio, J. Trujillano-Cabello, E. Barallat-Gimeno, and R. Fainsinger
- Subjects
medicine.medical_specialty ,Medical education ,Traditional medicine ,business.industry ,Alternative medicine ,language.human_language ,Anesthesiology and Pain Medicine ,Neurology ,language ,medicine ,Catalan ,Neurology (clinical) ,Cancer pain ,business - Published
- 2016
22. [Risk factors for the deterioration of quality of life in critical trauma patients. Assessment at 6 and 12 months after discharge from the intensive care unit]
- Author
-
L, Serviá Goixart, M, Badia Castelló, N, Montserrat Ortiz, G, Bello Rodriguez, E, Vicario Izquierdo, J, Vilanova Corselles, and J, Trujillano Cabello
- Subjects
Adult ,Male ,Time Factors ,Critical Illness ,Middle Aged ,Risk Assessment ,Patient Discharge ,Intensive Care Units ,Risk Factors ,Quality of Life ,Humans ,Wounds and Injuries ,Female ,Prospective Studies - Abstract
To evaluate factors influencing the deterioration of health-related quality of life (HRQoL) in trauma patients admitted to an ICU.A prospective observational study was carried out.The combined medical/surgical ICU in a university secondary hospital with 24-hour neurosurgery service.Trauma patients admitted to the ICU during a two-year period. HRQoL assessment prior to admission to the ICU, and at 6 and 12 months after discharge.Demographic variables, type and severity of injury (AIS), severity (APACHE II, ISS, TRISS), length of stay, procedures, mortality and HRQoL according to the SF-36 and EQ-5D.We completed the monitoring of 110 patients that showed significant impairment of their HRQoL in all the dimensions assessed. According to the SF-36, physical role was more deteriorated at 12 months, but the mental component decreased more than the physical component after 6 months. The VAS scale of the EQ-5D decreased to 55 at 6 months (19) and increased to 66 at 12 months (17). In the multiple logistic regression analysis, the variables associated with poorer HRQoL were age45 years, TRISS10, previous porer quality of life, and serious injuries in the extremities.Patients showed marked deterioration of their HRQoL at 6 months, followed by overall improvement at 12 months, though without reaching their previous state. The factors that determine poorer quality of life include age, severity, previous HRQoL, and severe injuries in the extremities.
- Published
- 2012
23. [Randomised comparative study of early versus delayed surgery in hip-fracture patients on concomitant treatment with antiplatelet drugs. Determination of platelet aggregation, perioperative bleeding and a review of annual mortality]
- Author
-
J, Mas-Atance, C, Marzo-Alonso, M, Matute-Crespo, J J, Trujillano-Cabello, N, Català-Tello, M, de Miguel-Artal, P, Forcada-Calvet, and J J, Fernández-Martínez
- Subjects
Aged, 80 and over ,Male ,Time Factors ,Platelet Aggregation ,Hip Fractures ,Early Medical Intervention ,Humans ,Female ,Prospective Studies ,Platelet Aggregation Inhibitors - Abstract
A review of the perioperative management of patients with hip fractures and concomitant therapy with antiplatelet agents, and to analyse the differences in mortality and perioperative bleeding in early surgery (48 h) versus delayed surgery (5 days). Platelet aggregation was measured on admission and immediately before surgery in all patients included in the studyA total of 175 patients over 65 years old, with low energy hip fracture were randomised into 3 groups: Patients on antiplatelet therapy undergoing early surgery, patients on antiplatelet therapy undergoing delayed surgery, and patients not on antiplatelet therapy undergoing early surgery. The same clinical and laboratory data were collected prospectively up to 12 months for all the patients. The platelet aggregation was determined by a semi-quantitative computerised system based on impedance aggregometry in whole blood.Bleeding, transfusion requirements and analytical results showed no significant differences between groups. More than half (59.8%) of the patients not taking antiplatelet therapy had normal platelet aggregation on admission, while 13.5% of those taking antiplatelet agents did not. Multivariate analysis showed increased mortality at 12 months for the variables, low Barthel index before hip fracture (OR: 0.9-0.9) and number of transfusions (OR: 1.1-1.5). The average lenth of stay was 4.1 days greater in the delayed surgery group.Early surgery for patients receiving antiplatelet therapy has similar clinical outcomes to the delayed, but improves hospital efficiency by reducing the average length of stay. The antiplatelet drug reported by the patient showed low concordance with the determination of the platelet aggregation.
- Published
- 2011
24. [Changes in health-related quality of life after ICU according to diagnostic category. Comparison of two measurement instruments]
- Author
-
M, Badia Castelló, J, Trujillano Cabello, L, Serviá Goixart, J, March Llanes, and A, Rodríguez-Pozo
- Subjects
Adult ,Male ,Intensive Care Units ,Critical Care ,Surveys and Questionnaires ,Diagnosis ,Quality of Life ,Humans ,Female ,Prospective Studies ,Middle Aged ,Aged - Abstract
Assessment of health related quality of life (HRQOL) before and 12 months after discharge from a mixed intensive care unit (ICU) according to diagnostic category and the relationship between both instruments.Prospective observational study.The combined medical/surgical ICU in a secondary university hospital with 450 beds.Patients admitted to the ICU over an 18-month period.Variables on demography, diagnosis on admission, severity of acute illness score (APACHE II), length of stay, procedures, mortality and the HRQOL were collected using the Short Form SF-36 and EQ-5D questionnaires. Health status prior to admission was evaluated retrospectively.Both questionnaires were answered by 189 patients. A significant deterioration in the quality of life was observed 12 months after ICU discharge. Head injury and neurological patients had worse HRQOL one year after discharge. Multiple trauma patients presented severe physical limitations and pain, but without significant differences on the emotional level. The EQ Visual Analogue Scale and the EQ Index score showed clinically relevant differences in these three groups. Respiratory patients are the only group in whom the HRQOL improved. Comparison between both measurement instruments showed a strong correlation on the physical functioning level, but a weaker correlation on the emotional functioning one.HRQOL assessment of ICU patients must be done according to a diagnostic category. Both instruments (the EQ-5D and SF-36) are capable of detecting changes in HRQOL. Despite differences in structure and content, both measure similar aspects of quality of life.
- Published
- 2008
25. [Locating the site of resistance to the endotracheal tube in fiberoptic oral intubation and maneuvers to overcome it: a mannequin simulation study]
- Author
-
H, Obón Monforte, A, Romagosa Valls, J, Trujillano Cabello, R, González Enguita, L F, Guerrero de la Rotta, and J M, Sistac Ballarín
- Subjects
Bronchoscopes ,Rotation ,Intubation, Intratracheal ,Fiber Optic Technology ,Equipment Design ,Stress, Mechanical ,Manikins ,Algorithms - Abstract
To determine the most common tracheal points of resistance during orotracheal insertion of a fiberoptic tube in a mannequin by applying a maneuver algorithm to overcome the resistance.Four study groups were established to compare 2 types of endotracheal tube: a standard tube and a reinforced flexible tube with an internal diameter of 7.5 mm. The tubes were used on their own or in combination with a Williams airway intubator. Two fiberoptic bronchoscopes were used, one to perform the test intubation and the other to observe the location of resistance and the effectiveness of the maneuvers for overcoming it. The degree of resistance was scored using a modified Jones scale, from 0 (intubation without resistance) to 4 (intubation impossible); location of resistance and time required for each intubation were also recorded.A total of 250 oral intubations were performed. Resistance was encountered in 75.2% of the cases. The main locations of obstruction were the right arytenoid cartilage and the posterior commissure. In 89.6% of the cases, intubation of the trachea was achieved without maneuvering or with a 90 degrees counterclockwise rotation. Statistically significant differences were found in resistance and intubation time when the reinforced flexible tube was used with the Williams intubator.Rotating the tube 90 degrees counterclockwise was an effective maneuver for overcoming resistance. The combination of a reinforced flexible tube and a Williams intubator was associated with less resistance and shorter intubation times.
- Published
- 2008
26. (122) Neuropathic pain in a sample of nicotine addicted advanced cancer patients: practical outcomes using the DN4 tool
- Author
-
A. Martin-Marco, E. Barallat-Gimeno, J. Canal-Sotelo, and J. Trujillano-Cabello
- Subjects
medicine.medical_specialty ,business.industry ,Sample (statistics) ,Advanced cancer ,Nicotine ,Anesthesiology and Pain Medicine ,Neurology ,Anesthesia ,Neuropathic pain ,Physical therapy ,Medicine ,Neurology (clinical) ,business ,medicine.drug - Published
- 2014
27. (156) Nicotine and alcohol addiction in advanced cancer patients; any relationship with pain outcomes?
- Author
-
J. Canal-Sotelo, E. Barallat-Gimeno, and J. Trujillano-Cabello
- Subjects
Nicotine ,medicine.medical_specialty ,Anesthesiology and Pain Medicine ,Neurology ,Alcohol addiction ,business.industry ,medicine ,Neurology (clinical) ,Psychiatry ,business ,Advanced cancer ,medicine.drug - Published
- 2014
28. [Identification of patients with a high risk of needing prolonged mechanical ventilation after coronary surgery]
- Author
-
M, León-Vallés, M A, Suárez-Pinilla, J M, Abad-Díez, L, Carreras-Gargallo, J J, Trujillano-Cabello, and T, Sanz-Gonzalo
- Subjects
Male ,Risk ,Incidence ,Middle Aged ,Respiration Disorders ,Respiration, Artificial ,Severity of Illness Index ,Postoperative Complications ,Predictive Value of Tests ,Multivariate Analysis ,Humans ,Female ,Prospective Studies ,Coronary Artery Bypass - Abstract
To identify patients at greater risk of developing respiratory complications, defined as the need for mechanical ventilation (MV) longer than 48 h, following revascularization surgery.This was a prospective analysis of 39 variables in 107 consecutive operations taking place over 9 months. We studied the association of these variables with the need for prolonged MV after surgery, by way of single variable and multivariate analysis.The incidence of prolonged MV was 7.7% and the 25% rate of mortality in the group of patients with this complication was significantly higher than the 0% mortality in the remaining patients. After single variable analysis of the data, the following variables were more significantly (p0.01) associated with the need for postoperative MV longer than 48 h: presence of other cardiac lesions other than coronary disease, performance of other heart surgery along with the coronary revascularization, surgical complications, high left auricular pressure soon after surgery. The variables found to have the highest independent predictive value based on the multivariate analysis were performance of other heart surgery along with the coronary revascularization and surgical complications.Our study indicates that the variables that point to poor left ventricular function and negative repercussions on extracorporeal circulation are associated with a greater incidence of prolonged MV after coronary surgery. Keeping these variables in mind allows high risk patients to be identified. More extensive monitoring of breathing function and therapeutic measures can then be implemented for better postoperative management.
- Published
- 1996
29. [Impact of surgical aggression and postoperative septic problems on fibronectin levels]
- Author
-
J, Trujillano Cabello, M, León Vallés, E, Campos Gutiérrez, V, Palacios Rubio, A, Cabezas Sánchez, and M L, Calvo Ruato
- Subjects
Adult ,Male ,Postoperative Complications ,Stress, Physiological ,Preoperative Care ,Humans ,Female ,Blood Proteins ,Prospective Studies ,Middle Aged ,Infections ,Aged ,Fibronectins - Abstract
The following study has been carried out in order to assess the repercussion of surgery on fibronectin (F) levels and its course, whether or not septic complications are presented. The F, albumin (ALB), prealbumin (PREALB), retinol binding protein (RBP) and alpha-1-glycoprotein (GLYCO) levels were controlled in 37 patients (29 undergoing scheduled digestive tract surgery and 8 undergoing heart surgery), through preoperative and postoperative tests every three days. A group of 40 healthy controls was taken as reference. Group I contained 19 patients free of septic complications, statistically significant changes were observed in PREALB and RBP levels but not in F, although a decrease was observed which return to normal by the third test. Group II contained 18 patients which were subdivided into: a) 12 patients suffering from brief septic complication without known focus of infection and, b) 6 patients suffering from more severe septic complication with known focus of infection. The IIA subgroup showed a significant decrease in all protein levels, returning to normal levels by the sixth or seventh day. Subgroup IIB showed lower F levels, which did not return to normal before the ninth day. CONCLUSION. Preoperative controls were similar in I and IIa, while IIB showed significantly lower values. Although F decreased in the first preoperative control, it was not statistically significant. Patients not suffering from complications showed F recuperation within the first week, which was not the case of septic patients. Due to the wide number of functions of F and of the factors that influence it, we believe it should not be interpreted on a single basis a nutritional parameters.
- Published
- 1990
30. Implementation of a major trauma team. Analysis of activation and care times in patients admitted to the ICU.
- Author
-
Montserrat Ortiz N, Trujillano Cabello J, Badia Castelló M, Vilanova Corsellas J, Jimenez Jimenez G, Rubio Ruiz J, Pujol Freire A, Morales Hernandez D, and Servia Goixart L
- Subjects
- Male, Humans, Aged, Middle Aged, Prospective Studies, Injury Severity Score, Retrospective Studies, Hospitalization, Intensive Care Units
- Abstract
Objective: To analyze the factors associated with the activation of the severe trauma care team (STAT) in patients admitted to the ICU, to measure its impact on care times, and to analyze the groups of patients according to activation and level of anatomical involvement., Design: Prospective cohort study of severe trauma admitted to the ICU. From June 2017 to May 2019. Risk factors for the activation of the STAT analysed with logistic regression and CART type classification tree., Setting: Second level hospital ICU., Patients: Patients admitted consecutively., Interventions: No., Main Variables of Interest: STAT activation. Demographic variables. Injury severity (ISS), intentionality, mechanism, assistance times, evolutionary complications, and mortality., Results: A total of 188 patients were admitted (46.8% of STAT activation), median age of 52 (37-64) years (activated 47 (27-62) vs not activated 55 (42-67) P = 0.023), males 84.0%. No difference in mortality according to activation. The logistic model finds as factors: care (16.6 (2.1-13.2)) and prehospital intubation (4.2 (1.8-9.8)) and severe lower extremity injury (4.4 (1.6-12.3)). Accidental fall (0.2 (0.1-0.6)) makes activation less likely. The CART model selects the type of trauma mechanism and can separate high and low energy trauma., Conclusions: Factors associated with STAT activation were prehospital care, requiring prior intubation, high-energy mechanisms, and severe lower extremity injuries. Shorter care times if activated without influencing mortality. We must improve activation in older patients with low-energy trauma and without prehospital care., (Copyright © 2022 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
31. Results of a preoperative screening and decolonization program for Staphylococcus aureus in primary hip and knee arthroplasty.
- Author
-
Yuste Berenguer E, Colomina Morales J, Señor Revuelto P, Drudis Morell R, Torra Riera M, Pilares Ortega EP, and Trujillano Cabello J
- Abstract
Introduction: Detection and decolonization of Staphylococcus aureus prior to surgery is postulated as an option to reduce the risk of infection in arthroplasties. The aim of this study was to evaluate the effectiveness of a screening program for S. aureus in total knee arthroplasty (TKA) and total hip arthroplasty (THA), the incidence of infection with respect to a historical cohort, and its economic viability., Material and Methods: Pre-post intervention study in patients undergoing primary knee and hip prostheses in 2021, a protocol was carried out to detect nasal colonization by S. aureus and eradication if appropriate, with intranasal mupirocin, post-treatment culture with results three weeks between post-treatment culture and surgery. Efficacy measures are evaluated, costs are analyzed and the incidence of infection is compared with respect to a historical series of patients operated on between January and December 2019, performing a descriptive and comparative statistical analysis., Results: The groups were statistically comparable. Culture was performed in 89%, with 19 (13%) positive patients. Treatment was confirmed in 18, control culture in 14, all decolonized; none suffered infection. One culture-negative patient suffered from Staphylococcus epidermidis infection. In historical cohort: 3 suffered deep infection by S. epidermidis, Enterobacter cloacae, S. aureus. The cost of the program is €1661.85., Conclusion: The screening program detected 89% of the patients. The prevalence of infection in the intervention group was lower than in the cohort, with S. epidermidis being the main microorganism, different from S. aureus described in the literature and in the cohort. We believe that this program is economically viable, as its costs are low and affordable., (Copyright © 2022 SECOT. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. [Translated article] Results of a preoperative screening and decolonization programme for Staphylococcus aureus in primary hip and knee arthroplasty.
- Author
-
Yuste Berenguer E, Colomina Morales J, Señor Revuelto P, Drudis Morell R, Torra Riera M, Pilares Ortega EP, and Trujillano Cabello J
- Abstract
Introduction: Detection and decolonization of Staphylococcus aureus prior to surgery is postulated as an option to reduce the risk of infection in arthroplasties. The aim of this study was to evaluate the effectiveness of a screening programme for S. aureus in total knee arthroplasty (TKA) and total hip arthroplasty (THA), the incidence of infection with respect to a historical cohort, and its economic viability., Material and Methods: Pre-post intervention study in patients undergoing primary knee and hip prostheses in 2021, a protocol was carried out to detect nasal colonization by S. aureus and eradication if appropriate, with intranasal mupirocin, post-treatment culture with results three weeks between post-treatment culture and surgery. Efficacy measures are evaluated, costs are analyzed and the incidence of infection is compared with respect to a historical series of patients operated on between January and December 2019, performing a descriptive and comparative statistical analysis., Results: The groups were statistically comparable. Culture was performed in 89%, with 19 (13%) positive patients. Treatment was confirmed in 18, control culture in 14, all decolonized; none suffered infection. One culture-negative patient suffered from Staphylococcus epidermidis infection. In historical cohort: three suffered deep infection by S. epidermidis, Enterobacter cloacae, Staphylococcus aureus. The cost of the programme is €1661.85., Conclusion: The screening programme detected 89% of the patients. The prevalence of infection in the intervention group was lower than in the cohort, with S. epidermidis being the main micro-organism, different from S. aureus described in the literature and in the cohort. We believe that this programme is economically viable, as its costs are low and affordable., (Copyright © 2022 SECOT. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Time to sputum conversion in patients with pulmonary tuberculosis: A score to estimate the infectious period.
- Author
-
Ramirez-Hidalgo M, Trujillano-Cabello J, Espluges-Vidal A, Reñé-Reñé M, Santín M, Sánchez-Montalvá A, Bernet-Sánchez A, Gros-Navés L, and Falguera M
- Abstract
Introduction: Patients with pulmonary tuberculosis (PTB) disease and positive sputum cultures are the main source of infection. Culture conversion time is inconsistent and defining the length of respiratory isolation is challenging. The objective of this study is to develop a score to predict the length of isolation period., Methods: A retrospective study was carried out to evaluated risk factors associated with persistent positive sputum cultures after 4 weeks of treatment in 229 patients with PTB. A multivariable logistic regression model was used to determinate predictors for positive culture and a scoring system was created based on the coefficients of the final model., Results: Sputum culture was persistently positive in 40.6%. Fever at consultation (1.87, 95% CI:1.02-3.41), smoking (2.44, 95% CI:1.36-4.37), >2 affected lung lobes (1.95, 95% CI:1.08-3.54), and neutrophil-to-lymphocyte ratio > 3.5 (2.22, 95% CI:1.24-3.99), were significantly associated with delayed culture conversion. Therefore, we assembled a severity score that achieved an area under the curve of 0.71 (95% CI:0.64-0.78)., Conclusions: In patients with smear positive PTB, a score with clinical, radiological and analytical parameters can be used as a supplemental tool to assist clinical decisions in isolation period., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
34. The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
- Author
-
Lopez-Delgado JC, Grau-Carmona T, Trujillano-Cabello J, García-Fuentes C, Mor-Marco E, Bordeje-Laguna ML, Portugal-Rodriguez E, Lorencio-Cardenas C, Vera-Artazcoz P, Macaya-Redin L, Martinez-Carmona JF, Mateu-Campos L, Gero-Escapa M, Gastaldo-Simeon R, Vila-García B, Flordelis-Lasierra JL, Montejo-Gonzalez JC, Servia-Goixart L, and The Enpic Study Group
- Subjects
- Critical Illness therapy, Food, Formulated, Humans, Nutritional Support, Enteral Nutrition, Intensive Care Units
- Abstract
Background: The present research aimed to evaluate the effect on outcomes of immunonutrition (IMN) enteral formulas during the intensive care unit (ICU) stay. Methods: A multicenter prospective observational study was performed. Patient characteristics, disease severity, nutritional status, type of nutritional therapy and outcomes, and laboratory parameters were collected in a database. Statistical differences were analyzed according to the administration of IMN or other types of enteral formulas. Results: In total, 406 patients were included in the analysis, of whom 15.02% (61) received IMN. Univariate analysis showed that patients treated with IMN formulas received higher mean caloric and protein intake, and better 28-day survival (85.2% vs. 73.3%; p = 0.014. Unadjusted Hazard Ratio (HR): 0.15; 95% CI (Confidence Interval): 0.06−0.36; p < 0.001). Once adjusted for confounding factors, multivariate analysis showed a lower need for vasopressor support (OR: 0.49; 95% CI: 0.26−0.91; p = 0.023) and continuous renal replacement therapies (OR: 0.13; 95% CI: 0.01−0.65; p = 0.049) in those patients who received IMN formulas, independently of the severity of the disease. IMN use was also associated with higher protein intake during the administration of nutritional therapy (OR: 6.23; 95% CI: 2.59−15.54; p < 0.001), regardless of the type of patient. No differences were found in the laboratory parameters, except for a trend toward lower triglyceride levels (HR: 0.97; 95% CI: 0.95−0.99; p = 0.045). Conclusion: The use of IMN formulas may be associated with better outcomes (i.e., lower need for vasopressors and continuous renal replacement), together with a trend toward higher protein enteral delivery during the ICU stay. These findings may ultimately be related to their modulating effect on the inflammatory response in the critically ill. NCT Registry: 03634943.
- Published
- 2022
- Full Text
- View/download PDF
35. Evaluation of Nutritional Practices in the Critical Care patient (The ENPIC study): Does nutrition really affect ICU mortality?
- Author
-
Servia-Goixart L, Lopez-Delgado JC, Grau-Carmona T, Trujillano-Cabello J, Bordeje-Laguna ML, Mor-Marco E, Portugal-Rodriguez E, Lorencio-Cardenas C, Montejo-Gonzalez JC, Vera-Artazcoz P, Macaya-Redin L, Martinez-Carmona JF, Iglesias-Rodriguez R, Monge-Donaire D, Flordelis-Lasierra JL, Llorente-Ruiz B, Menor-Fernández EM, Martínez de Lagrán I, and Yebenes-Reyes JC
- Subjects
- Adult, Critical Care, Enteral Nutrition, Humans, Parenteral Nutrition, Intensive Care Units, Nutritional Status
- Abstract
Background & Aims: The importance of artificial nutritional therapy is underrecognized, typically being considered an adjunctive rather than a primary therapy. We aimed to evaluate the influence of nutritional therapy on mortality in critically ill patients., Methods: This multicenter prospective observational study included adult patients needing artificial nutritional therapy for >48 h if they stayed in one of 38 participating intensive care units for ≥72 h between April and July 2018. Demographic data, comorbidities, diagnoses, nutritional status and therapy (type and details for ≤14 days), and outcomes were registered in a database. Confounders such as disease severity, patient type (e.g., medical, surgical or trauma), and type and duration of nutritional therapy were also included in a multivariate analysis, and hazard ratios (HRs) and 95% confidence intervals (95%CIs) were reported., Results: We included 639 patients among whom 448 (70.1%) and 191 (29.9%) received enteral and parenteral nutrition, respectively. Mortality was 25.6%, with non-survivors having the following characteristics: older age; more comorbidities; higher Sequential Organ Failure Assessment (SOFA) scores (6.6 ± 3.3 vs 8.4 ± 3.7; P < 0.001); greater nutritional risk (Nutrition Risk in the Critically Ill [NUTRIC] score: 3.8 ± 2.1 vs 5.2 ± 1.7; P < 0.001); more vasopressor requirements (70.4% vs 83.5%; P=0.001); and more renal replacement therapy (12.2% vs 23.2%; P=0.001). Multivariate analysis showed that older age (HR: 1.023; 95% CI: 1.008-1.038; P=0.003), higher SOFA score (HR: 1.096; 95% CI: 1.036-1.160; P=0.001), higher NUTRIC score (HR: 1.136; 95% CI: 1.025-1.259; P=0.015), requiring parenteral nutrition after starting enteral nutrition (HR: 2.368; 95% CI: 1.168-4.798; P=0.017), and a higher mean Kcal/Kg/day intake (HR: 1.057; 95% CI: 1.015-1.101; P=0.008) were associated with mortality. By contrast, a higher mean protein intake protected against mortality (HR: 0.507; 95% CI: 0.263-0.977; P=0.042)., Conclusions: Old age, higher organ failure scores, and greater nutritional risk appear to be associated with higher mortality. Patients who need parenteral nutrition after starting enteral nutrition may represent a high-risk subgroup for mortality due to illness severity and problems receiving appropriate nutritional therapy. Mean calorie and protein delivery also appeared to influence outcomes., Trial Registration: ClinicaTrials.gov NCT: 03634943., (Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
36. Design and Validation of a Computer Application for Diagnosis of Shoulder Locomotor System Pathology.
- Author
-
Bigorda-Sague A, Trujillano Cabello J, Ariza Carrio G, and Campoy Guerrero C
- Abstract
Objectives: To design and validate a computer application for the diagnosis of shoulder locomotor system pathology., Methods: The first phase involved the construction of the application using the Delphi method. In the second phase, the application was validated with a sample of 250 patients with shoulder pathology. Validity was measured for each diagnostic group using sensitivity, specificity, and positive and negative likelihood ratio (LR(+) and LR(-)). The correct classification ratio (CCR) for each patient and the factors related to worse classification were calculated using multivariate binary logistic regression (odds ratio, 95% confidence interval)., Results: The mean time to complete the application was 15 ± 7 minutes. The validity values were the following: LR(+) 7.8 and LR(-) 0.1 for cervical radiculopathy, LR(+) 4.1 and LR(-) 0.4 for glenohumeral arthrosis, LR(+) 15.5 and LR(-) 0.2 for glenohumeral instability, LR(+) 17.2 and LR(-) 0.2 for massive rotator cuff tear, LR(+) 6.2 and LR(-) 0.2 for capsular syndrome, LR(+) 4.0 and LR(-) 0.3 for subacromial impingement/rotator cuff tendinopathy, and LR(+) 2.5 and LR(-) 0.6 for acromioclavicular arthropathy. A total of 70% of the patients had a CCR greater than 85%. Factors that negatively affected accuracy were massive rotator cuff tear, acromioclavicular arthropathy, age over 55 years, and high pain intensity ( p < 0.05)., Conclusions: The developed application achieved an acceptable validity for most pathologies. Because the tool had a limited capacity to identify the full clinical picture in the same patient, improvements and new studies applied to other groups of patients are required., Competing Interests: Conflict of Interest: No potential conflict of interest relevant to this article was reported.
- Published
- 2019
- Full Text
- View/download PDF
37. Survey on the assessment of nutritional status and feedback syndrome in Spanish intensive care units.
- Author
-
Zamora Elson M, Trujillano Cabello J, González Iglesias C, Bordejé Laguna ML, Fernández Ortega JF, and Vaquerizo Alonso C
- Subjects
- Critical Care organization & administration, Humans, Malnutrition diagnosis, Malnutrition diet therapy, Nutrition Assessment, Nutritional Status, Phosphorus blood, Prescriptions, Refeeding Syndrome etiology, Risk, Risk Factors, Severity of Illness Index, Societies, Medical, Spain, Water-Electrolyte Imbalance etiology, Water-Electrolyte Imbalance prevention & control, Intensive Care Units, Nutrition Surveys, Refeeding Syndrome epidemiology
- Published
- 2018
- Full Text
- View/download PDF
38. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
- Author
-
Canal-Sotelo J, Trujillano-Cabello J, Larkin P, Arraràs-Torrelles N, González-Rubió R, Rocaspana-Garcia M, and Barallat-Gimeno E
- Subjects
- Aged, Algorithms, Breakthrough Pain epidemiology, Cancer Pain epidemiology, Female, Hospitals, Teaching, Humans, Lung Neoplasms epidemiology, Lung Neoplasms physiopathology, Male, Retrospective Studies, Spain epidemiology, Breakthrough Pain diagnosis, Cancer Pain diagnosis, Pain Measurement methods
- Abstract
Background: Breakthrough cancer pain (BTcP) is defined according to its principal characteristics: high intensity, short time interval between onset and peak intensity, short duration, potential recurrence over 24 h and non-responsiveness to standard analgesic regimes. The Edmonton Classification System for Cancer Pain (ECS-CP) is a classification tool that evaluates different dimensions of pain. The aim of this study was to measure prevalence and the main characteristics of BTcP in a sample of advanced cancer patients and to explore the complexity observed when ECS-CP is incorporated into BTcP diagnostics algorithm., Methods: Descriptive prevalence study (Retrospective chart review). Davies' algorithm was used to identify BTcP and ECS-CP was used to recognize appropriate dimensions of pain. The study was conducted in a sample of advanced cancer patients attending hospital outpatient clinic in Lleida, Spain. 277 patients were included from 01/01/2014 to 31/12/2015. No direct contact was made with participants. The following information was extracted from the palliative care outpatient clinic database: age, gender, civil status, cognitive impairment status, functional performance status and variables related to tumour. Only BTcP cases were included., Results: Prevalence of BTcP was 39.34% (63.9% men). Mean of age was 68.2 years. Main diagnosis was lung cancer (n = 154; 31.6%). Metastases were diagnosed in 83% of the sample. 138 patients (49.8%) were diagnosed with 1 type of BTcP and 139 (50.2%) were diagnosed with more than one type of BTcP. In total, 488 different types of BTcP were recorded (mean 1.75 ± 0, 9), 244 of these types (50%) presented a component of neuropathic pain. Addictive behaviour, measured through CAGE test, was present in 29.2% (N = 81) of the patients and psychological distress was present in 40.8% (n = 113)., Conclusions: Prevalence of BTcP (39.34%) is similar to the one reflected in the existing literature. Study results indicate that the routine use of ECS-CP in a clinical setting allows us to detect more than one type of BTcP as well as additional complexity associated with pain (neuropathic, addictive behavior and psychological distress).
- Published
- 2018
- Full Text
- View/download PDF
39. [Incidence and predictive factors of iron deficiency anemia after acute non-variceal upper gastrointestinal bleeding without portal hypertension].
- Author
-
Planella de Rubinat M, Teixidó Amorós M, Ballester Clau R, Trujillano Cabello J, Ibarz Escuer M, and Reñé Espinet JM
- Subjects
- Adult, Aged, Aged, 80 and over, Anemia, Iron-Deficiency epidemiology, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Anticoagulants adverse effects, Decision Trees, Disease Progression, Endoscopy, Gastrointestinal, Female, Ferritins blood, Hemoglobins analysis, Humans, Incidence, Logistic Models, Male, Middle Aged, Models, Biological, Peptic Ulcer Hemorrhage complications, Prospective Studies, Recurrence, Risk Factors, Transferrin analysis, Young Adult, Anemia, Iron-Deficiency etiology, Esophageal and Gastric Varices complications, Gastrointestinal Hemorrhage complications
- Abstract
Introduction: There are few studies on iron deficiency anemia (IDA) after non-variceal acute upper gastrointestinal bleeding (UGIB) in patients without portal hypertension., Objectives: To define the incidence of IDA after UGIB, to characterize the predictive factors for IDA and to design algorithms that could help physicians identify those patients who could benefit from iron therapy., Material and Method: We registered 391 patients with UGIB between April 2007 and May 2009. Patients with portal hypertension and those with clinical or/and biological conditions that could affect the ferrokinetic pattern were excluded. Blood analyses were performed, including ferric parameters upon admission, on the 5th day, and on the 30th day after the hemorrhage episode. We used a multiple logistic regression model and a classification and regression tree model., Results: A total of 124 patients were included, of which 76 (61.3%) developed IDA 30 days after UGIB. The predictive variables were age >75 years (P=.037; OR 3.9; 95% CI: 1.3-11.6), initial urea level >80mg/dL (P=.027; OR 2.9; 95% CI: 1.1-7.6), initial ferritin level ≤65ng/dL (P=.002; OR 7.6; 95% CI: 2.9-18.5), initial hemoglobin level ≤100g/L (P=.003; OR 3.2; 95% CI: 1.3-8.0), hemoglobin level on the 5th day ≤100g/L (P<.001; OR 14.9; 95% CI: 3.6-61.1) and the value of the transferrin saturation index on the 5th day <10% (p<0.001; OR 7.2; 95% CI: 2.6-20.3)., Conclusions: Most patients with UGIB developed IDA 30 days after the episode. Identification of the predictive factors for IDA may help to establish guidelines for the administration of iron therapy., (Copyright © 2015 Elsevier España, S.L.U. and AEEH y AEG. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
40. [Risk factors for the deterioration of quality of life in critical trauma patients. Assessment at 6 and 12 months after discharge from the intensive care unit].
- Author
-
Serviá Goixart L, Badia Castelló M, Montserrat Ortiz N, Bello Rodriguez G, Vicario Izquierdo E, Vilanova Corselles J, and Trujillano Cabello J
- Subjects
- Adult, Critical Illness, Female, Humans, Intensive Care Units, Male, Middle Aged, Patient Discharge, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, Quality of Life, Wounds and Injuries complications
- Abstract
Objective: To evaluate factors influencing the deterioration of health-related quality of life (HRQoL) in trauma patients admitted to an ICU., Design: A prospective observational study was carried out., Setting: The combined medical/surgical ICU in a university secondary hospital with 24-hour neurosurgery service., Patients: Trauma patients admitted to the ICU during a two-year period. HRQoL assessment prior to admission to the ICU, and at 6 and 12 months after discharge., Main Variables: Demographic variables, type and severity of injury (AIS), severity (APACHE II, ISS, TRISS), length of stay, procedures, mortality and HRQoL according to the SF-36 and EQ-5D., Results: We completed the monitoring of 110 patients that showed significant impairment of their HRQoL in all the dimensions assessed. According to the SF-36, physical role was more deteriorated at 12 months, but the mental component decreased more than the physical component after 6 months. The VAS scale of the EQ-5D decreased to 55 at 6 months (19) and increased to 66 at 12 months (17). In the multiple logistic regression analysis, the variables associated with poorer HRQoL were age > 45 years, TRISS > 10, previous porer quality of life, and serious injuries in the extremities., Conclusions: Patients showed marked deterioration of their HRQoL at 6 months, followed by overall improvement at 12 months, though without reaching their previous state. The factors that determine poorer quality of life include age, severity, previous HRQoL, and severe injuries in the extremities., (Copyright © 2012 Elsevier España, S.L. and SEMICYUC. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
41. Occult donor metastatic adenocarcinoma. Contribution of the forensic autopsy. A case report.
- Author
-
Badia Castello M, Trujillano Cabello J, Serviá Goixart L, Tarragona Foradada J, Panades Siurana MJ, and Amoròs Galito E
- Subjects
- Adenocarcinoma complications, Adenocarcinoma pathology, Aged, Autopsy, Brain Death pathology, Humans, Male, Neoplasms complications, Risk, Adenocarcinoma etiology, Kidney Transplantation adverse effects, Neoplasms etiology, Nephrectomy adverse effects, Tissue Donors
- Abstract
Background: The transmission of malignancies from the organ donor to the recipients is an uncommon complication, but it can be fatal. Older donors may increase the risk of tumor transmission. A forensic autopsy will help identify diseases that might be transmitted to the recipient., Case Report: Donor was a 75-year-old man with traumatic brain injury caused by an accidental fall, which led to brain death. He had no previous cancer history. The forensic autopsy conducted on the following day revealed a suspicious spot in the lung, on which a biopsy was done. Histological examination confirmed the presence of a metastatic adenocarcinoma in the lung 7 days after both kidneys had been transplanted. After notifying the transplant team, both recipients underwent an early transplant nephrectomy. 15 months later, no signs of malignancy have been detected in the recipients and so they have received a new transplant., Conclusions: Conducting a forensic autopsy on donors deceased as a result of a fatality offers an additional opportunity to detect previously undiagnosed malignancies. Any suspicious lesion found that could compromise transplant viability should be notified to the transplant team notwithstanding the pathologist's legal requirements. This case shows the need for an exhaustive donor evaluation, including, in selected cases, the performance of an autopsy.
- Published
- 2010
42. [Changes in health-related quality of life after ICU according to diagnostic category. Comparison of two measurement instruments].
- Author
-
Badia Castelló M, Trujillano Cabello J, Serviá Goixart L, March Llanes J, and Rodríguez-Pozo A
- Subjects
- Adult, Aged, Female, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Critical Care, Diagnosis, Quality of Life, Surveys and Questionnaires
- Abstract
Objective: Assessment of health related quality of life (HRQOL) before and 12 months after discharge from a mixed intensive care unit (ICU) according to diagnostic category and the relationship between both instruments., Design: Prospective observational study., Setting: The combined medical/surgical ICU in a secondary university hospital with 450 beds., Patients: Patients admitted to the ICU over an 18-month period., Main Variables: Variables on demography, diagnosis on admission, severity of acute illness score (APACHE II), length of stay, procedures, mortality and the HRQOL were collected using the Short Form SF-36 and EQ-5D questionnaires. Health status prior to admission was evaluated retrospectively., Results: Both questionnaires were answered by 189 patients. A significant deterioration in the quality of life was observed 12 months after ICU discharge. Head injury and neurological patients had worse HRQOL one year after discharge. Multiple trauma patients presented severe physical limitations and pain, but without significant differences on the emotional level. The EQ Visual Analogue Scale and the EQ Index score showed clinically relevant differences in these three groups. Respiratory patients are the only group in whom the HRQOL improved. Comparison between both measurement instruments showed a strong correlation on the physical functioning level, but a weaker correlation on the emotional functioning one., Conclusions: HRQOL assessment of ICU patients must be done according to a diagnostic category. Both instruments (the EQ-5D and SF-36) are capable of detecting changes in HRQOL. Despite differences in structure and content, both measure similar aspects of quality of life.
- Published
- 2008
- Full Text
- View/download PDF
43. [Locating the site of resistance to the endotracheal tube in fiberoptic oral intubation and maneuvers to overcome it: a mannequin simulation study].
- Author
-
Obón Monforte H, Romagosa Valls A, Trujillano Cabello J, González Enguita R, Guerrero de la Rotta LF, and Sistac Ballarín JM
- Subjects
- Algorithms, Bronchoscopes, Equipment Design, Fiber Optic Technology, Intubation, Intratracheal instrumentation, Rotation, Stress, Mechanical, Intubation, Intratracheal methods, Manikins
- Abstract
Objective: To determine the most common tracheal points of resistance during orotracheal insertion of a fiberoptic tube in a mannequin by applying a maneuver algorithm to overcome the resistance., Method: Four study groups were established to compare 2 types of endotracheal tube: a standard tube and a reinforced flexible tube with an internal diameter of 7.5 mm. The tubes were used on their own or in combination with a Williams airway intubator. Two fiberoptic bronchoscopes were used, one to perform the test intubation and the other to observe the location of resistance and the effectiveness of the maneuvers for overcoming it. The degree of resistance was scored using a modified Jones scale, from 0 (intubation without resistance) to 4 (intubation impossible); location of resistance and time required for each intubation were also recorded., Results: A total of 250 oral intubations were performed. Resistance was encountered in 75.2% of the cases. The main locations of obstruction were the right arytenoid cartilage and the posterior commissure. In 89.6% of the cases, intubation of the trachea was achieved without maneuvering or with a 90 degrees counterclockwise rotation. Statistically significant differences were found in resistance and intubation time when the reinforced flexible tube was used with the Williams intubator., Conclusions: Rotating the tube 90 degrees counterclockwise was an effective maneuver for overcoming resistance. The combination of a reinforced flexible tube and a Williams intubator was associated with less resistance and shorter intubation times.
- Published
- 2007
44. [Recall and memory after intensive care unit stay. Development of posttraumatic stress disorder].
- Author
-
Badia-Castelló M, Trujillano-Cabello J, Serviá-Goixart L, March-Llanes J, and Rodríguez-Pozo A
- Subjects
- Critical Illness psychology, Critical Illness therapy, Delusions diagnosis, Delusions etiology, Delusions psychology, Female, Humans, Intensive Care Units statistics & numerical data, Length of Stay, Logistic Models, Male, Memory, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Severity of Illness Index, Stress Disorders, Post-Traumatic diagnosis, Stress Disorders, Post-Traumatic psychology, Surveys and Questionnaires, Critical Care psychology, Mental Recall, Stress Disorders, Post-Traumatic etiology
- Abstract
Background and Objective: The intensive care unit (ICU) confers a stress on patients and may affect the memory. The aim of the study was to examine the memory after critical care and the relationship with therapy and the development of posttraumatic stress disorder., Patients and Method: Prospectively study conducted between December 2001 and June 2003. Patients were excluded if language difficulties or had a neurologic or psychiatric disease. We collected data on gender and age, length of stay in the ICU, severity of acute illness, diagnoses and medical treatment with mechanical ventilation, propofol, midazolam and dopamine during the ICU stay. 12 months after ICU eligible patients were contacted to assess memory. The ICUM (Intensive Care Memory) tool and IES (Impact Event Scale) were used to assess memory and posttraumatic stress disorder., Results: A total of 169 patients were included. The incidence of memory was 77.6%. 41 patients recalled delusional memories and these patients had higher IES after discharge. The logistic regression suggested a relationship with propofol, dopamine and length of stay., Conclusions: ICU treatment may be related more to recall of delusions. The delusional memory is associated with posttraumatic stress disorder symptoms after ICU.
- Published
- 2006
- Full Text
- View/download PDF
45. [The evaluation of enteral nutritional support in the critical patient].
- Author
-
Campos Gutiérrez E, Palacios Rubio V, Trujillano Cabello J, León Valles M, Tejada Artigas A, and Sánchez Pardo F
- Subjects
- Aged, Evaluation Studies as Topic, Female, Humans, Male, Middle Aged, Nutritional Requirements, Nutritional Status, Prospective Studies, Time Factors, Critical Care statistics & numerical data, Enteral Nutrition adverse effects, Enteral Nutrition statistics & numerical data
- Abstract
Unlabelled: A prospective study of 40 patients for a period of 9 months was conducted, in order to evaluate the tolerance, clinical evolution and nutritional parameters in critical patients on enteral nutrition. In all cases, nutrients were administered enterally, by nasogastric tube and the administration method selected was continuous perfusion in most cases. 78.5 +/- 17% of estimated Kcal. were administered. During the study, the following aspects were studied: fasting time, type of diet, time during which enteral nutrition (EN) was maintained and reason for suspension, degree of derivation using nasogastric tube (NGT), number of bowel movements per day, antibiotic therapy ad gastric protection drugs as well as drugs administered for supporting mechanical ventilation and the evolution of the patient. Evolutional controls of the nutritional state were also conducted. Tolerance was seen to be good, especially in patients on continuous perfusion. With regard to the evolution of nutritional parameters, we observed maintenance of proteic levels with a slight recovery of retinol-binding protein (RBP) and no statistically significant differences between patients who died and those with a favourable development. The level of oligoelements was maintained, although below normal levels., Conclusions: EN is the ideal selection for the nutritional support of critical patients with functionally usefull gastrointestinal tracts. A good digestive tolerance was observed, and proteic levels maintained were similar to the initial ones, although with this type of diet, we recommend an additional intake of iron.
- Published
- 1992
46. [Impact of surgical aggression and postoperative septic problems on fibronectin levels].
- Author
-
Trujillano Cabello J, León Vallés M, Campos Gutiérrez E, Palacios Rubio V, Cabezas Sánchez A, and Calvo Ruato ML
- Subjects
- Adult, Aged, Blood Proteins analysis, Female, Humans, Male, Middle Aged, Preoperative Care, Prospective Studies, Fibronectins blood, Infections blood, Postoperative Complications blood, Stress, Physiological blood
- Abstract
The following study has been carried out in order to assess the repercussion of surgery on fibronectin (F) levels and its course, whether or not septic complications are presented. The F, albumin (ALB), prealbumin (PREALB), retinol binding protein (RBP) and alpha-1-glycoprotein (GLYCO) levels were controlled in 37 patients (29 undergoing scheduled digestive tract surgery and 8 undergoing heart surgery), through preoperative and postoperative tests every three days. A group of 40 healthy controls was taken as reference. Group I contained 19 patients free of septic complications, statistically significant changes were observed in PREALB and RBP levels but not in F, although a decrease was observed which return to normal by the third test. Group II contained 18 patients which were subdivided into: a) 12 patients suffering from brief septic complication without known focus of infection and, b) 6 patients suffering from more severe septic complication with known focus of infection. The IIA subgroup showed a significant decrease in all protein levels, returning to normal levels by the sixth or seventh day. Subgroup IIB showed lower F levels, which did not return to normal before the ninth day. CONCLUSION. Preoperative controls were similar in I and IIa, while IIB showed significantly lower values. Although F decreased in the first preoperative control, it was not statistically significant. Patients not suffering from complications showed F recuperation within the first week, which was not the case of septic patients. Due to the wide number of functions of F and of the factors that influence it, we believe it should not be interpreted on a single basis a nutritional parameters.
- Published
- 1990
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.